Document:

Exhibit 10.2

 

Confidential

 

FIRST AMENDMENT TO LICENSE AGREEMENT

 

This FIRST AMENDMENT TO LICENSE AGREEMENT is entered
into as of the 10th day of June, 2021 (the “Amendment”) by and among INMUNE BIO, INC., a Nevada corporation (“INmune”),
having a principal place of business at 1224 Prospect Street, Suite 150, La Jolla, California 92037, and XENCOR, INC., a Delaware corporation
(“Xencor”), having a principal place of business at 111 West Lemon Avenue, Monrovia, California 91016, U.S.A.

 

RECITALS

 

WHEREAS, INmune and Xencor have entered
into a Licensing Agreement effective as of October 3, 2017, a copy of which is attached hereto as Exhibit A (the “License Agreement”);
and

 

WHEREAS, INmune and Xencor desire to amend
Sections 3.2 and 4.2 of the License Agreement concerning Development and Commercialization, Diligence; Royalties; and Sublicensing Revenue,
respectively.

 

NOW, THEREFORE, in consideration of the
terms and conditions set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agree as follows:

 

1. Definitions.
Each initially capitalized term used herein without definition shall have the meaning ascribed to such term in the License Agreement.

 

2. Amendments.

 

2.1 It
is hereby agreed that Section 3.2 of the License Agreement, shall be amended, effective as of the date hereof, to read in its entirety
as follows:

 

“3.2 Due Diligence.

 

(a) INmune
shall, and shall require its Affiliates and Sublicensees to, use Commercially Reasonable Efforts to achieve the following due
diligence milestones and to develop and obtain Regulatory Approval of Licensed Products in the Field and, after such Regulatory
Approval is obtained, commercialize one or more Licensed Products in the Field.

 

	Due diligence milestone	 	Due date
	Initiation of a pivotal trial of a Licensed Product in the Field	 	Seventh (7th) anniversary of the Effective Date
	Submission of application for a marketing authorization to a regulatory body for a Licensed Product in the Field	 	Ninth (9th) anniversary of the Effective Date

 

     

     

    

 

(b) Extension
of diligence milestone. INmune may extend the diligence due date for any diligence milestone for up to two successive one (1) year periods
of time to comply with the diligence requirements of Section 3.2(a), as long as it (i) is otherwise in material compliance with the terms
of this Agreement, (ii) provides a written request for the diligence extension to Xencor prior to the diligence due date, and (ii) pays
to Xencor a One Hundred Thousand dollar (US$100,000) fee prior to the expiration of the diligence due date for each year.

 

(c) If INmune has
not met the due diligence milestones listed in Section 3.2(a), Xencor may furnish INmune written notice of the determination
thereof. Within 30 days after receipt of such notice, INmune shall either (i) fulfill the relevant obligation, or (ii) provide to
Xencor a mutually acceptable schedule of revised due diligence obligations and plans to meet the same. In the case of subclause (ii)
in the preceding sentence, INmune and Xencor shall meet and discuss such revised obligations and plans, and Xencor shall consider
such revisions in good faith. If Xencor does not find the revised obligations and plans acceptable in its sole discretion, Xencor
may, immediately upon written notice to INmune, terminate this Agreement either in its entirety or, in Xencor’s sole
discretion, with respect to one or more Licensed Products.”

 

2.2 It
is hereby agreed that Section 4.2 of the License Agreement shall be amended, effective as of the date hereof, to read in its entirety
as follows:

 

“4.2 Royalties.
Subject to the terms and conditions of this Agreement, in consideration of the rights and licenses granted by Xencor herein, INmune
shall pay Xencor a royalty of 5% on Net Sales of all Licensed Products in the given calendar year. The royalties due pursuant to this
Section 4.2 shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis until the date which is the later
of: (a) the expiration of the last to expire Valid Claim covering such Licensed Product in such country, or (b) 10 years following the
First Commercial Sale of a first of any Licensed Product in such country.” 

 

3.  Full
Force and Effect. Except as specifically modified or amended by the terms of this Amendment, the License Agreement and all provisions
contained therein are, and shall continue, in full force and effect and are hereby ratified and confirmed.

 

4. Counterparts.
This Amendment may be executed in any number of separate counterparts, each of which shall be deemed to be an original and all of which
together shall be deemed to be one and the same instrument. Alternatively, this Amendment may be executed by electronic signatures.

 

5. Miscellaneous.
This Amendment shall be binding upon all the parties to the License Agreement and their respective successors and assigns.

 

[Signature Page Follows]

 

    Page 2 of 3

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year
first above written.

 

	 	INMUNE BIO, INC.
	 	 
	 	By: 	/s/ Raymond J. Tesi
	 	Name:  	Raymond J. Tesi
	 	Title: 	Chief Executive Officer
	 	 
	 	XENCOR, INC.
	 	 
	 	By:	/s/ Bassil I. Dahiyat
	 	Name:   	Bassil I. Dahiyat
	 	Title:	President and Chief Executive Officer

 

 

Page 3 of 3Exhibit 10.3

 

LOAN
AND SECURITY AGREEMENT

 

THIS
LOAN AND SECURITY AGREEMENT (this “Agreement”) is dated as of the Effective Date among (a) SILICON VALLEY BANK,
a California corporation (“SVB”), in its capacity as administrative agent and collateral agent (“Agent”),
(b) SVB, as a lender, (c) SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership (“SVB Capital”),
as a lender (SVB and SVB Capital and each of the other “Lenders” from time to time a party hereto are referred to herein
collectively as the “Lenders” and each individually as a “Lender”), and (d) the borrower listed
on Schedule I hereto (“Borrower”). The parties agree as follows:

 

 1 LOAN AND TERMS OF PAYMENT

 

 1.1 Term Loan Advances.

 

(a) Availability.
Subject to the terms and conditions of this Agreement, the Lenders, severally and not jointly, shall make one (1) term loan advance to
Borrower on or about the Effective Date in an original principal amount of Fifteen Million Dollars ($15,000,000) according to each Lender’s
Term Loan Advance Commitment as set forth on Schedule II hereto (after referred to singly as a “Term Loan Advance”
and collectively as the “Term Loan Advances”). Borrower may request Term Loan Advances as set forth on Schedule I
hereto.

 

Additionally,
at any time during the term of this Agreement, Borrower may request that Lenders make one (1) additional term loan
advance available to Borrower, during the Uncommitted Accordion Draw Period, in an original principal amount equal to Five Million
Dollars ($5,000,000 (the “Uncommitted Accordion”). Lenders, in their sole and absolute discretion, may grant or
deny any such request from Borrower for a term loan advance under the Uncommitted Accordion. If, and only if, Lenders, in their sole
discretion, agree to provide an additional term loan advance to Borrower under the Uncommitted Accordion, the term loan advance
shall be considered a “Term Loan Advance” hereunder and added to the definition thereof and also shall be
considered added to each Lender’s Term Loan Advance Commitment in accordance with the Term Loan Advance Commitment Percentage
as set forth on Schedule II hereto.

 

(b) Repayment.
Borrower shall repay the aggregate outstanding Term Loan Advances as set forth in Schedule I hereto. All outstanding principal and accrued
and unpaid interest with respect to the Term Loan Advances, and all other outstanding Obligations under the Term Loan Advances, are due
and payable in full on the Term Loan Maturity Date.

 

(c) Permitted
Prepayment. Borrower shall have the option to prepay all, but not less than all, of the Term Loan Advances advanced by the Lenders
under this Agreement, provided Borrower (i) provides written notice to Agent of its election to prepay the Term Loan Advances at least
ten (10) days prior to such prepayment, and (ii) pays to Agent, for the account of the Lenders in accordance with their respective Pro
Rata Share, on the date of such prepayment (A) all outstanding principal plus accrued and unpaid interest, (B) the Prepayment Premium,
(C) the Final Payment and (D) all other sums, if any, that shall have become due and payable, including Lenders’ Expenses and interest
at the Default Rate with respect to any past due amounts.

 

(d) Mandatory
Prepayment Upon an Acceleration. If the Term Loan Advances are accelerated by Agent, following the occurrence and during the continuance
of an Event of Default, Borrower shall immediately pay to Agent, for the account of the Lenders in accordance with their respective Pro
Rata Share, an amount equal to the sum of (i) all outstanding principal plus accrued and unpaid interest with respect to the Term Loan
Advances, (ii) the Prepayment Premium, (iii) the Final Payment and (iv) all other sums, if any, that shall have become due and payable,
including Lenders’ Expenses and interest at the Default Rate with respect to any past due amounts.

 

 1.2 Payment of Interest on the Credit Extensions.

 

(a) Interest
Payments. Interest on the principal amount of each Term Loan Advance is payable as set forth on Schedule I hereto.

 

     

     

    

 

(b) Interest
Rate. Subject to Section 1.2(c), the outstanding principal amount of any Term Loan Advance shall accrue interest as set forth on
Schedule I hereto.

 

(c) Default
Rate. Immediately upon the occurrence and during the continuance of an Event of Default, the outstanding Obligations shall bear interest
at a rate per annum which is five percent (5.0%) above the rate that is otherwise applicable thereto (the “Default Rate”).
Fees and expenses which are required to be paid by Borrower pursuant to the Loan Documents (including, without limitation, Lenders’
Expenses) but are not paid when due shall bear interest until paid at a rate equal to the highest rate applicable to the Obligations.
Payment or acceptance of the increased interest rate provided in this Section 1.2(c) is not a permitted alternative to timely payment
and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Agent or any Lender.

 

(d) Adjustment
to Interest Rate. Each change in the interest rate applicable to any amounts payable under the Loan Documents based on changes to
the Prime Rate shall be effective on the effective date of any change to the Prime Rate and to the extent of such change.

 

(e) Interest
Computation. Interest shall be computed as set forth on Schedule I hereto. In computing interest, the date of the making of any Credit
Extension shall be included and the date of payment shall be excluded; provided, however, that if any Credit Extension is repaid on the
same day on which it is made, such day shall be included in computing interest on such Credit Extension.

 

 1.3 Fees and Expenses. Borrower shall pay to Agent:

 

(a) Final
Payment. The Final Payment, when due hereunder, to be shared between the Lenders pursuant to their respective Term Loan Commitment
Percentages, which shall be fully earned and non-refundable as of such date;

 

(b) Prepayment
Premium. The Prepayment Premium, when due hereunder, to be shared between the Lenders pursuant to their respective Term Loan Commitment
Percentages, which shall be fully earned and non-refundable as of such date; and

 

(c) Lenders’
Expenses. All Lenders’ Expenses (including reasonable attorneys’ fees and expenses for documentation and negotiation
of this Agreement) incurred through and after the Effective Date, when due (or, if no stated due date, upon demand by Agent). Borrower
has paid to Agent a good faith deposit of Seventy-Five Thousand Dollars ($75,000) (the “Good Faith Deposit”) to initiate
Lenders’ due diligence review process. The Good Faith Deposit will be applied to Lenders’ Expenses as of the Effective Date.

 

Unless
otherwise provided in this Agreement or in a separate writing by Agent, Borrower shall not be entitled to any credit, rebate, or repayment
of any fees earned by Agent or any Lender pursuant to this Agreement notwithstanding any termination of this Agreement or the suspension
or termination of any Lender’s obligation to make loans and advances hereunder. Agent may deduct amounts owing by Borrower under
the clauses of this Section 1.3 pursuant to the terms of Section 1.4(e). Agent shall provide Borrower written notice of deductions made
pursuant to the terms of the clauses of this Section 1.3. Notwithstanding anything to the contrary herein, on or promptly after the Funding
Date of the Term Loan Advance, the Lenders shall return the Good Faith Deposit to the Borrower minus Lenders’ Expenses (including
reasonable attorneys’ fees and expenses for documentation and negotiation of this Agreement) incurred through and after the Effective
Date.

 

 1.4 Payments; Pro Rata Treatment; Application of Payments; Debit of Accounts.

 

(a) All
payments (including prepayments) to be made by Borrower under any Loan Document shall be made to Agent for the account of Lenders, in
immediately available funds in Dollars, without setoff, counterclaim, or deduction, before 12:00 p.m. Pacific time on the date when due.
Agent shall distribute such payments to Lenders in like funds as set forth in Section 1.5. Payments of principal and/or interest received
after 12:00 p.m. Pacific time are considered received at the opening of business on the next Business Day. When a payment is due on a
day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall
continue to accrue until paid.

 

    2

     

    

 

(b) Each
borrowing by Borrower from Lenders hereunder shall be made according to the respective Term Loan Commitment Percentages of the relevant
Lenders.

 

(c) Except
as otherwise provided herein, each payment (including each prepayment) by Borrower on account of principal or interest on the Term Loan
Advances shall be applied according to each Lender’s Pro Rata Share of the outstanding principal amount of the Term Loan Advances.
The amount of each principal prepayment of the Term Loan Advances shall be applied to reduce the then remaining installments of the Term
Loan Advances based upon each Pro Rata Share of Term Loan Advances.

 

(d) Agent
has the exclusive right to determine the order and manner in which all payments with respect to the Obligations may be applied. Borrower
shall have no right to specify the order or the accounts to which Agent shall allocate or apply any payments required to be made by Borrower
to Agent or otherwise received by Agent or any Lender under this Agreement when any such allocation or application is not specified elsewhere
in this Agreement.

 

(e) Agent
may debit any of Borrower’s deposit accounts maintained with Agent, including the Designated Deposit Account, for principal and
interest payments or any other amounts Borrower owes Agent or any Lender when due under the Loan Documents. These debits shall not constitute
a set-off.

 

(f) Unless
Agent shall have been notified in writing by Borrower prior to the date of any payment due to be made by Borrower hereunder that Borrower
will not make such payment to Agent, Agent may assume that Borrower is making such payment, and Agent may, but shall not be required
to, in reliance upon such assumption, make available to Lenders their respective Pro Rata Share of a corresponding payment amount. If
such payment is not made to Agent by Borrower within three (3) Business Days after such due date, Agent shall be entitled to recover,
on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest
thereon at the rate per annum equal to the daily average Federal Funds Effective Rate. Nothing herein shall be deemed to limit the rights
of Agent or any Lender against Borrower.

 

1.5
Settlement Procedures. If Agent receives any payment for the account of Lenders on or prior to 12:00 p.m. (Pacific time) on any
Business Day, Agent shall pay to each applicable Lender such Lender’s Pro Rata Share of such payment on such Business Day. If
Agent receives any payment for the account of Lenders after 12:00 p.m. (Pacific time) on any Business Day, Agent shall pay to each
applicable Lender such Lender’s Pro Rata Share of such payment on the next Business Day.

 

1.6
Withholding by Borrower. Payments received by Agent, for the account of Lenders, from Borrower under this Agreement will be made
free and clear of and without deduction for any and all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments,
fees or other charges imposed by any Governmental Authority (including any interest, additions to tax or penalties applicable thereto).
Specifically, however, if at any time any Governmental Authority, applicable law, regulation or international agreement requires Borrower
to make any withholding or deduction from any such payment or other sum payable hereunder to Agent, Borrower hereby covenants and agrees
that the amount due from Borrower with respect to such payment or other sum payable hereunder will be increased to the extent necessary
to ensure that, after the making of such required withholding or deduction (including any required withholding or deduction with respect
to the increased amount), Agent receives a net sum equal to the sum which it would have received had no withholding or deduction been
required, and Borrower shall pay the full amount withheld or deducted to the relevant Governmental Authority. Borrower will, upon request,
furnish Agent with proof reasonably satisfactory to Agent indicating that Borrower has made such withholding payment; provided, however,
that Borrower need not make any withholding payment if the amount or validity of such withholding payment is contested in good faith
by appropriate and timely proceedings and as to which payment in full is bonded or reserved against by Borrower. Borrower will indemnify
and hold harmless Agent and the Lenders for, and upon written request of Agent reimburse Agent and the Lenders for the amount of, any
taxes levied or imposed on or paid by Agent or any lender (whether or not correctly levied, imposed or paid) as a result of (i) Borrower’s
failure to withhold such taxes and pay them to the relevant Governmental Authority, or (ii) any indemnification or reimbursement paid
hereunder. The agreements and obligations of Borrower contained in this Section 1.6 shall survive the termination of this Agreement.

 

    3

     

    

 

 1.7 Change in Circumstances.

 

(a) Increased
Costs. If any Change in Law shall: (i) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance
charge or similar requirement against assets of, deposits with or for the account of, or advances, loans or other credit extended or
participated in by, Agent, (ii) subject Agent to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through
(d) of the definition of Excluded Taxes, and (C) Connection Income Taxes) on its loans, loan principal, letters of credit, commitment,
or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto, or (iii) impose on Agent any other
condition, cost or expense (other than Taxes) affecting this Agreement or Credit Extensions made by Agent, and the result of any of the
foregoing shall be to increase the cost to Agent of making, converting to, continuing or maintaining any Credit Extension (or of maintaining
its obligation to make any such Credit Extension), or to reduce the amount of any sum received or receivable by Agent hereunder (whether
of principal, interest or any other amount) then, upon written request of Agent, Borrower shall promptly pay to Agent such additional
amount or amounts as will compensate Agent for such additional costs incurred or reduction suffered.

 

(b) Capital
Requirements. If Agent determines that any Change in Law affecting Agent regarding capital or liquidity requirements, has or
would have the effect of reducing the rate of return on Agent’s capital as a consequence of this Agreement, any term loan
facility, or the Credit Extensions made by Agent to a level below that which Agent could have achieved but for such Change in Law
(taking into consideration Agent’s policies with respect to capital adequacy and liquidity), then from time to time upon
written request of Agent, Borrower shall promptly pay to Agent such additional amount or amounts as will compensate Agent for any
such reduction suffered.

 

(c) Delay
in Requests. Failure or delay on the part of Agent to demand compensation pursuant to this Section 1.7 shall not constitute a waiver
of Agent’s right to demand such compensation; provided that Borrower shall not be required to compensate Agent pursuant to subsection
(a) for any increased costs incurred or reductions suffered more than nine (9) months prior to the date that Agent notifies Borrower
of the Change in Law giving rise to such increased costs or reductions (except that if the Change in Law giving rise to such increased
costs or reductions is retroactive, then the nine (9) month period shall be extended to include the period of retroactive effect).

 

 1.8 Taxes.

 

(a) Payments
Free of Taxes. Any and all payments by or on account of any obligation of Borrower under any Loan Document shall be made without
deduction or withholding for any Taxes, except as required by Applicable Law. If any Applicable Law (as determined in the good faith
discretion of Borrower) requires the deduction or withholding of any Tax from any such payment by Borrower, then (i) Borrower shall be
entitled to make such deduction or withholding, (ii) Borrower shall timely pay the full amount deducted or withheld to the relevant Governmental
Authority in accordance with Applicable Law, and (iii) if such Tax is an Indemnified Tax, the sum payable by Borrower shall be increased
as necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional
sums payable under this Section 1.8) Agent receives an amount equal to the sum it would have received had no such deduction or withholding
been made.

 

(b) Payment
of Other Taxes by Borrower. Without limiting the provisions of subsection (a) above, Borrower shall timely pay any Other Taxes to
the relevant Governmental Authority in accordance with Applicable Law.

 

(c) Tax
Indemnification. Without limiting the provisions of subsections (a) and (b) above, Borrower shall, and does hereby, indemnify Agent,
within ten (10) days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted
on or attributable to amounts payable under this Section 1.8) payable or paid by Agent or required to be withheld or deducted from a
payment to Agent and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly
or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered
to Borrower by Agent shall be conclusive absent manifest error.

 

    4

     

    

 

(d) Evidence
of Payments. As soon as practicable after any payment of Taxes by Borrower to a Governmental Authority pursuant to this Section 1.8,
Borrower shall deliver to Agent a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of
the return reporting such payment or other evidence of such payment reasonably satisfactory to Agent.

 

(e) Status
of Agent. If Agent (including any assignee or successor) is entitled to an exemption from or reduction of withholding tax with respect
to payments made under any Loan Document, it shall deliver to Borrower, at the time or times reasonably requested by Borrower, such properly
completed and executed documentation reasonably requested by Borrower as will permit such payments to be made without withholding or
at a reduced rate of withholding. In addition, Agent, if reasonably requested by Borrower, shall deliver such other documentation prescribed
by Applicable Law or reasonably requested by Borrower as will enable Borrower to determine whether or not Agent is subject to backup
withholding or information reporting requirements. Without limiting the generality of the foregoing, Agent shall deliver whichever of
IRS Form W-9, IRS Form W-8BEN-E, IRS Form W-8ECI or W-8IMY is applicable, as well as any applicable supporting documentation or certifications.

 

 1.9 Procedures for Borrowing.

 

(a) Term
Loan Advances. Subject to the prior satisfaction of all other applicable conditions to the making of a Credit Extension set forth
in this Agreement (which must be satisfied no later than 12:00 p.m. Pacific time on the applicable Funding Date), to obtain a Credit
Extension, Borrower shall notify Agent (which notice shall be irrevocable) by 12:00 p.m. Pacific time at least five (5) Business Days
prior to the proposed Funding Date of such Credit Extension. Such notice shall be made by electronic mail, facsimile, or telephone, and,
together with any such notification, Borrower shall deliver to Agent by electronic mail or facsimile a completed Disbursement Letter
(and Payment/Advance Form) executed by an Authorized Signer. Agent may rely on any telephone notice given by a person whom Agent believes
is an Authorized Signer. Borrower will indemnify Agent for any loss Agent suffers due to such belief or reliance. Agent shall have received
satisfactory evidence that the Board has approved that such Authorized Signer may provide such notices and request Credit Extensions
(which requirement may be deemed satisfied by the prior delivery of Borrowing Resolutions that certifies as to such Board approval).

 

(b) On
the Funding Date, Agent shall credit the Credit Extensions to the Designated Deposit Account. Agent may make Credit Extensions under
this Agreement based on instructions from an Authorized Signer or without instructions if the Credit Extensions are necessary to meet
Obligations which have become due.

 

(c) Funding.
In determining compliance with any condition hereunder to the making of a Credit Extension that, by its terms, must be fulfilled to the
satisfaction of a Lender, Agent may presume that such condition is satisfactory to such Lender unless Agent shall have received notice
to the contrary from such Lender prior to the making of such Credit Extension. Unless Agent shall have been notified in writing by any
Lender prior to the date of any Credit Extension, that such Lender will not make the amount that would constitute its share of such borrowing
available to Agent, Agent may assume that such Lender is making such amount available to Agent, and Agent may, in reliance upon such
assumption, make available to Borrower a corresponding amount. If such amount is not made available to Agent by the required time on
the Funding Date therefor, such Lender shall pay to Agent, on demand, such amount with interest thereon, at a rate equal to the greater
of (i) the Federal Funds Effective Rate or (ii) a rate determined by Agent in accordance with banking industry rules on interbank compensation,
for the period until such Lender makes such amount immediately available to Agent. If such Lender’s share of such Credit Extension
is not made available to Agent by such Lender within three (3) Business Days after such Funding Date, Agent shall also be entitled to
recover such amount with interest thereon at the rate per annum applicable to the Term Loan Advances, on demand, from Borrower.

 

 2 CONDITIONS OF CREDIT EXTENSIONS

 

2.1
Conditions Precedent to Initial Credit Extension. Each Lender’s obligation to make the initial Credit Extension hereunder is
subject to the condition precedent that Agent shall have received, in form and substance satisfactory to Agent and the Lenders, such
documents, and completion of such other matters, as Agent may reasonably deem necessary or appropriate, including, without limitation:

 

 (a) duly executed Loan Documents;

 

    5

     

    

 

(b) duly executed Warrant;

 

(c) if
any, the certificate(s) for the outstanding capital stock, membership units or other securities owned or held of record by a Borrower
in any Subsidiary of such Borrower and an assignment separate certificate, duly executed by the pledgor in blank;

 

(d) the
Operating Documents of Borrower and long-form good standing certificates of Borrower certified by the Secretary of State of the State
of Nevada and the Secretary of State (or equivalent agency) of each other jurisdiction in which Borrower is qualified to conduct business,
in each case dated as of a date no earlier than thirty (30) days prior to the Effective Date;

 

(e) a
secretary’s certificate/officer’s certificate (as applicable) duly executed by a Responsible Officer or secretary of Borrower
with respect to Borrower’s Operating Documents, incumbency, specimen signatures and resolutions authorizing the execution and delivery
of this Agreement and the other Loan Documents to which it is a party;

 

 (f) duly executed Borrowing Resolutions for Borrower;

 

(g) certified
copies, dated as of a recent date, of searches for Liens (including without limitation, UCC searches) filed in the central filing office
of the State of Nevada and the State of California, accompanied by written evidence (including any UCC termination statements and other
Lien releases) that the Liens indicated in any such financing statements or other filings either constitute Permitted Liens or have been
or, in connection with the initial Credit Extension hereunder, will be terminated or released;

 

 (h) duly executed Perfection Certificate of Borrower;

 

(i) evidence
that all obligations of Borrower owing to Xencor in connection with Borrower’s warrant (option) in favor of Xencor have been satisfied
prior to or contemporaneously with the initial Credit Extension; and

 

 (j) payment of the fees and Lenders’ Expenses then due as specified in Section 1.3 hereof.

 

2.2
Conditions Precedent to all Credit Extensions. Each Lender’s obligation to make each Credit Extension, including the initial
Credit Extension, is subject to the following conditions precedent:

 

(a)
receipt of Borrower’s (i) executed Disbursement Letter and (ii) executed Payment/Advance Form;

 

(b)
duly executed original signatures to a Warrant (in the form attached hereto as Annex I hereto);

 

(c) the
representations and warranties in this Agreement shall be true and correct in all material respects as of the date of the Disbursement
Letter (and the Payment/Advance Form) and as of the Funding Date of each Credit Extension; provided, however, that such materiality qualifier
shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof;
and provided, further that those representations and warranties expressly referring to a specific date shall be true and correct in all
material respects as of such date, and no Default or Event of Default shall have occurred and be continuing or result from the Credit
Extension. Each Credit Extension is Borrower’s representation and warranty on that date that the representations and warranties
in this Agreement remain true and correct in all material respects; provided, however, that such materiality qualifier shall not be applicable
to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further
that those representations and warranties expressly referring to a specific date shall be true and correct in all material respects as
of such date; and

 

 (d) a Material Adverse Change shall not have occurred and be continuing.

 

    6

     

    

 

2.3
Covenant to Deliver. Borrower shall deliver to Agent and each Lender each item required to be delivered to Agent and each Lender
under this Agreement as a condition precedent to any Credit Extension. A Credit Extension made prior to the receipt by Agent and each
Lender of any such item shall not constitute a waiver by Agent or Lenders of Borrower’s obligation to deliver such item, and the
making of any Credit Extension in the absence of a required item shall be in each Lender’s sole discretion.

 

 3 CREATION OF SECURITY INTEREST

 

 3.1  Grant of Security Interest.

 

(a) Borrower
hereby grants Agent, for the ratable benefit of the Lenders, to secure the payment and performance in full of all of the Obligations,
a continuing security interest in, and pledges to Agent, for the ratable benefit of the Lenders, the Collateral, wherever located, whether
now owned or hereafter acquired or arising, and all proceeds and products thereof. For clarity, any reference to “Agent’s
Lien” or any granting of collateral to Agent in this Agreement or any Loan Document means the Lien granted to Agent for the ratable
benefit of the Lenders.

 

(b) Borrower
acknowledges that it previously has entered, or may in the future enter, into Bank Services Agreements with SVB. Regardless of the terms
of any Bank Services Agreement, Borrower agrees that any amounts Borrower owes SVB thereunder shall be deemed to be Obligations hereunder
and that it is the intent of Borrower and SVB to have all such Obligations secured by the first priority perfected security interest
in the Collateral granted herein (subject to Permitted Liens).

 

3.2
Authorization to File Financing Statements. Borrower hereby authorizes Agent, on behalf of the Lenders, to file financing statements,
without notice to Borrower, with all jurisdictions deemed necessary or appropriate by Agent to perfect or protect Agent’s and Lenders’
interest or rights hereunder, including a notice that any disposition of the Collateral, by Borrower or any other Person, shall be deemed
to violate the rights of Agent under the Code. Such financing statements may indicate the Collateral as “all assets of the Debtor”
or words of similar effect.

 

3.3
Termination. If this Agreement is terminated, Agent’s Lien in the Collateral shall continue until the Obligations (other than
inchoate indemnity obligations) are repaid in full in cash. Upon payment in full in cash of the Obligations (other than inchoate indemnity
obligations) and at such time as the Lenders’ obligation to make Credit Extensions has terminated, Agent shall, at Borrower’s
sole cost and expense, terminate its security interest in the Collateral and all rights therein shall revert to Borrower. In the event
(a) all Obligations (other than inchoate indemnity obligations), except for Bank Services, are satisfied in full, and (b) this Agreement
is terminated, Agent shall terminate the security interest granted herein upon Borrower providing to SVB cash collateral acceptable to
SVB in its sole discretion for Bank Services, if any. In the event such Bank Services consist of outstanding Letters of Credit, Borrower
shall provide to SVB cash collateral in an amount equal to at least (i) one hundred five percent (105.0%) of the face amount of all such
Letters of Credit denominated in Dollars and (ii) one hundred fifteen percent (115.0%) of the Dollar Equivalent of the face amount of
all such Letters of Credit denominated in a Foreign Currency, plus, in each case, all interest, fees, and costs due or estimated by SVB
to become due in connection therewith, to secure all of the Obligations relating to such Letters of Credit.

 

 4 REPRESENTATIONS AND WARRANTIES

 

Borrower
represents and warrants as follows:

 

 4.1 Due Organization, Authorization; Power and Authority.

 

(a) Borrower
and each of its Subsidiaries are each duly existing and in good standing as a Registered Organization in their respective jurisdiction
of formation and are qualified and licensed to do business and is in good standing in any jurisdiction in which the conduct of their
respective business or their ownership of property requires that they be qualified except where the failure to do so could not reasonably
be expected to have a material adverse effect on Borrower’s business or operations.

 

    7

     

    

 

(b) All
information set forth on the Perfection Certificate pertaining to Borrower and each of its Subsidiaries is true and correct (it being
understood and agreed that Borrower may from time to time update certain information in the Perfection Certificate after the Effective
Date to the extent permitted by one or more specific provisions in this Agreement and the Perfection Certificate shall be deemed to be
updated to the extent such notice is provided to Agent of such permitted update).

 

(c) The
execution, delivery and performance by Borrower and each of its Subsidiaries of the Loan Documents to which it is a party have been duly
authorized, and do not (i) conflict with any of Borrower’s or any such Subsidiary’s organizational documents, (ii) contravene,
conflict with, constitute a default under or violate any material Applicable Law, (iii) contravene, conflict with or violate any applicable
order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries
or any of their property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with,
or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are
in full force and effect), or (v) conflict with, contravene, constitute a default or breach under, or result in or permit the termination
or acceleration of, any material agreement by which Borrower or any of its Subsidiaries is bound. Neither Borrower nor any of its Subsidiaries
are in default under any agreement to which it is a party or by which it is bound in which the default could reasonably be expected to
have a material adverse effect on Borrower’s or any of its Subsidiary’s business or operations.

 

 4.2 Collateral.

 

(a) The
security interests granted herein are and shall at all times continue to be a first priority perfected security interests in the Collateral
(subject to Permitted Liens). Borrower has good title to, rights in, and the power to transfer each item of the Collateral upon which
it purports to grant a Lien hereunder, free and clear of any and all Liens except Permitted Liens.

 

(b) Borrower
has no Collateral Accounts at or with any bank or financial institution other than SVB or SVB’s Affiliates except for the Collateral
Accounts described in the Perfection Certificate delivered to Agent and each Lender in connection herewith and which Borrower has taken
such actions as are necessary to give Agent, for the ratable benefit of the Lenders, a perfected security interest therein, pursuant
to the terms of Section 5.7(c). The Accounts are bona fide, existing obligations of the Account Debtors.

 

(c) The
Collateral is not in the possession of any third party bailee (such as a warehouse) except as otherwise provided in the Perfection Certificate
or as permitted pursuant to Section 6.2. None of the components of the Collateral shall be maintained at locations other than as provided
in the Perfection Certificate or as permitted pursuant to Section 6.2.

 

(d)
All Inventory is in all material respects of good and marketable quality, free from material defects.

 

(e) Borrower
owns, or possesses the right to use to the extent necessary in its business, all Intellectual Property, licenses and other intangible
assets that are used in the conduct of its business as now operated, except to the extent that such failure to own or possess the right
to use such asset would not reasonably be expected to have a material adverse effect on Borrower’s business or operations, and
no such asset, to the best knowledge of Borrower, conflicts with the valid Intellectual Property, license, or intangible asset of any
other Person to the extent that such conflict could reasonably be expected to have a material adverse effect on Borrower’s business
or operations.

 

(f) Except
as noted on the Perfection Certificate, Borrower is not knowingly a party to, nor is it knowingly bound by, any Restricted License.

 

4.3
Litigation. Other than as set forth in the Perfection Certificate or as disclosed to Agent pursuant to Section 5.3(i), there are
no actions, investigations or proceedings pending or, to the knowledge of any Responsible Officer, threatened in writing by or against
Borrower or any of its Subsidiaries involving more than, individually or in the aggregate, One Hundred Thousand Dollars ($100,000).

 

    8

     

    

 

4.4
Financial Statements; Financial Condition. All consolidated financial statements for Borrower and any of its Subsidiaries delivered
to Agent and the Lenders by submission to the Financial Statement Repository or otherwise submitted to Agent fairly present in all material
respects Borrower’s consolidated financial condition and Borrower’s consolidated results of operations for the periods covered
thereby, subject, in the case of unaudited financial statements, to normal year-end adjustments and the absence of footnote disclosures.
There has not been any material deterioration in Borrower’s consolidated financial condition since the date of the most recent
financial statements submitted to the Financial Statement Repository or otherwise to Agent and the Lenders.

 

4.5
Solvency. The fair salable value of Borrower’s consolidated assets (including goodwill minus disposition costs) exceeds the
fair value of Borrower’s liabilities; Borrower is not left with unreasonably small capital after the transactions in this Agreement;
and Borrower and each of its Subsidiaries are able to pay their debts (including trade debts) as they mature.

 

4.6
Regulatory Compliance. Borrower is not an “investment company” or a company “controlled” by an “investment
company” under the Investment Company Act of 1940, as amended. Borrower is not engaged as one of its important activities in extending
credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower and each of its Subsidiaries
(a) have complied in all material respects with all Applicable Law, and (b) have not violated any Applicable Law the violation of which
could reasonably be expected to have a material adverse effect on Borrower’s business or operations. Borrower and each of its Subsidiaries
have duly complied with, and their respective facilities, business, assets, property, leaseholds, real property and Equipment are in
compliance with, Environmental Laws, except where the failure to do so could not reasonably be expected to have a material adverse effect
on Borrower’s business or operations; there have been no outstanding citations, notices or orders of non-compliance issued to Borrower
or any of its Subsidiaries or relating to their respective facilities, businesses, assets, property, leaseholds, real property or Equipment
under such Environmental Laws. Borrower and each of its Subsidiaries have obtained all consents, approvals and authorizations of, made
all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective
businesses as currently conducted, except where the failure to obtain or make or file the same would not reasonably be expected to have
a material adverse effect on Borrower’s business or operations.

 

4.7
Subsidiaries; Investments. Borrower does not own any stock, partnership, or other ownership interest or other equity securities except
for Permitted Investments.

 

 4.8 Tax Returns and Payments; Pension Contributions.

 

(a) Borrower
and each of its Subsidiaries have timely filed, or submitted extensions for, all required tax returns and reports, and Borrower and each
of its Subsidiaries have timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower
and each of its Subsidiaries except (i) to the extent such taxes are being contested in good faith by appropriate proceedings promptly
instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity
with GAAP shall have been made therefor, or (ii) if such taxes, assessments, deposits and contributions do not, individually or in the
aggregate, exceed Twenty-Five Thousand Dollars ($25,000.00). Borrower is unaware of any claims or adjustments proposed for any of Borrower’s
or any of its Subsidiary’s prior tax years which could result in additional taxes becoming due and payable by Borrower or any of
its Subsidiaries in excess of Twenty-Five Thousand Dollars ($25,000.00) in the aggregate.

 

(b) Borrower
and each of its Subsidiaries have paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans
in accordance with their terms, and neither Borrower nor any of its Subsidiaries has withdrawn from participation in, and has not permitted
partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably
be expected to result in any liability of Borrower or any of its Subsidiaries, including any liability to the Pension Benefit Guaranty
Corporation or its successors or any other Governmental Authority.

 

4.9
Full Disclosure. No written representation, warranty or other statement of Borrower or any of its Subsidiaries in any report, certificate
or written statement submitted to the Financial Statement Repository or otherwise submitted to Agent, as of the date such representation,
warranty, or other statement was made, taken together with all such reports, certificates and written statements submitted to the Financial
Statement Repository or otherwise submitted to Agent, contains any untrue statement of a material fact or omits to state a material fact
necessary to make the statements contained in the reports, certificates or written statements not misleading in light of the circumstances
under which they were made (it being recognized by Agent that the projections and forecasts provided by Borrower or any of its Subsidiaries
in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered
by such projections and forecasts may differ from the projected or forecasted results).

 

    9

     

    

 

4.10 Sanctions.
Neither Borrower nor any of its Subsidiaries is: (a) in violation of any Sanctions; or (b) a Sanctioned Person. Neither
Borrower nor any of its Subsidiaries, directors, officers, employees, agents or Affiliates: (i) conducts any business or
engages in any transaction or dealing with any Sanctioned Person, including making or receiving any contribution of funds, goods or
services to or for the benefit of any Sanctioned Person; (ii) deals in, or otherwise engages in any transaction relating to, any
property or interests in property blocked pursuant to any Sanctions; (iii) engages in or conspires to engage in any transaction that
evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any
Sanctions; or (iv) otherwise engages in any transaction that could cause Agent or the Lenders to violate any Sanctions.

 

4.11
Healthcare Permits. (a) Borrower has obtained all Healthcare Permits and other rights from, and has made all declarations and filings
with, all applicable Governmental Authorities, all self-regulatory authorities and all courts and other tribunals necessary to engage
in the management and/or operation of their respective business; (b) each such Healthcare Permit is valid and in full force and effect,
and Borrower is in compliance with the terms and conditions of all such Healthcare Permits; and (c) Borrower has not received notice
from any Governmental Authority with respect to the revocation, suspension, restriction, limitation or termination of any Healthcare
Permit nor, to the knowledge of Borrower, is any such action proposed or threatened in writing.

 

 4.12 Compliance with Healthcare Laws.

 

(a) Borrower
is in compliance with all applicable Healthcare Laws. Without limiting the generality of the foregoing, Borrower has not received written
notice by a governmental authority of any violation (or of any investigation, audit, or other proceeding involving allegations of any
violation) of any Healthcare Laws, and no investigation, inspection, audit or other proceeding involving allegations of any violation
is, to the knowledge of Borrower, threatened in writing or contemplated.

 

(b) To
the knowledge of Borrower, Borrower is not in default or violation of any law which is applicable to Borrower or its respective assets
or the conduct of its respective businesses and Borrower has not been debarred or excluded from participation under a state or federal
health care program, including any state or federal workers compensation program.

 

(c) Borrower
is not a party to any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement
orders or similar agreements with or imposed by any governmental authority.

 

 5 AFFIRMATIVE COVENANTS

 

Borrower
shall do all of the following:

 

5.1
Use of Proceeds. Cause the proceeds of the Credit Extensions to be used (a) as working capital, (b) to repay obligations of
Borrower owing to Xencor in connection with Borrower’s warrant in favor of Xencor, and/or (c) to
fund its general business purposes, and not for personal, family, household or agricultural purposes.

 

 5.2
Government Compliance.

 

(a) Maintain
its and all of its Subsidiaries’ legal existence (except as permitted under Section 6.3 with respect to Subsidiaries only) and
good standing in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to
so qualify would reasonably be expected to have a material adverse effect on Borrower’s business or operations. Borrower shall
comply, and have each Subsidiary comply, in all material respects, with all laws, ordinances and regulations to which it is subject.

 

    10

     

    

 

(b) Obtain
all of the Governmental Approvals necessary for the performance by Borrower and each of its Subsidiaries of their obligations under the
Loan Documents to which it is a party, including any grant of a security interest to Agent, for the ratable benefit of the Lenders, in
all of its property. Borrower shall promptly provide copies of any such obtained Governmental Approvals to Agent.

 

(c) Cause
the operations and property of Borrower, each of its Subsidiaries to comply with all applicable Healthcare Laws. Without limiting the
foregoing, the operations and property of Borrower and each of its Subsidiaries shall comply with HIPAA in all material respects. Borrower
established and maintains a corporate compliance program that (i) addresses the material Requirements of Law, including all applicable
Healthcare Laws, of Governmental Authorities having jurisdiction over its business and operations, and (ii) has been structured to account
for the guidance issued by the U.S. Department of Health and Human Services regarding characteristics of effective corporate compliance
programs. As of the Effective Date, Borrower has delivered to Agent and the Lenders an accurate and complete copy of each material report,
study, survey or other document of which Borrower has knowledge that addresses or otherwise relates to the compliance by Borrower and
each of its Subsidiaries, with applicable Healthcare Laws.

 

5.3
Financial Statements, Reports. Deliver to Agent and each Lender by submitting to the Financial Statement Repository:

 

(a) Monthly
Bank Statements. Within thirty (30) days after the last day of each month, copies of account statements from each financial institution,
other than SVB, where Borrower or its Subsidiaries maintains operating accounts, deposit accounts or securities accounts.

 

(b) Quarterly
Financial Statements. Subject to Section 5.3(f) below, as soon as available, but no later than forty-five (45) days after the last
day of each calendar quarter, a company prepared consolidated and consolidating (if applicable) balance sheet, cash flow statement, and
income statement covering Borrower’s and each of its Subsidiaries’ operations for such calendar quarter in a form consistent
with those filed with SEC; provided, however, that if any of the aforementioned deliverables are prepared but not filed with the SEC,
such deliverables should be provided to each Lender;

 

(c) Quarterly
Compliance Statement. Within forty-five (45) days after the last day of each quarterly end and together with the statements set forth
in Section 5.3(c), a duly completed Compliance Statement, confirming that as of the end of such quarterly end, Borrower was in full compliance
with all of the terms and conditions of this Agreement, and setting forth calculations showing compliance with the financial covenants
(if any) set forth in this Agreement and such other information as Agent or the Lenders may reasonably request;

 

(d) Annual
Operating Budget and Financial Projections. Within thirty (30) days after the last day of Borrower’s fiscal year, and contemporaneously
with any updates or amendments thereto, (i) annual operating budgets (including income statements, balance sheets and cash flow statements,
by month) for the upcoming fiscal year of Borrower, and (ii) annual financial projections for the following fiscal year (on a quarterly
basis), in each case as approved by the Board, together with any related business forecasts used in the preparation of such annual financial
projections;

 

 (e) Annual Audited Financial Statements. As soon as available, and in any event within ninety

 

(90) days
after the last day of Borrower’s fiscal year, audited consolidated financial statements prepared under GAAP, consistently applied,
together with an unqualified opinion on the financial statements from an independent certified public accounting firm reasonably acceptable
to Agent and in a form consistent with those filed with SEC;

 

(f) SEC
Filings. Within five (5) days of filing, notification of the filing and copies of all periodic and other reports, proxy statements
and other materials filed by Borrower and/or any of its Subsidiaries or any Guarantor with the SEC, any Governmental Authority succeeding
to any or all of the functions of the SEC or with any national securities exchange, or distributed to its shareholders, as the case may
be. Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise
filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date on which
Borrower or any of its Subsidiaries posts such documents, or provides a link thereto, on Borrower’s or any of its Subsidiaries’
website on the internet at Borrower’s or any of its Subsidiaries’ website address or on the date Borrower files such documents
with the SEC on sec.gov.

 

    11

     

    

 

(g) Security
Holder and Subordinated Debt Holder Reports. Within five (5) days of delivery, copies of all statements, reports and notices made
available to Borrower’s security holders or to any holders of Subordinated Debt (solely in their capacities as security holders
or holders of Subordinated Debt and not in any other role);

 

(h) Beneficial
Ownership Information. Prompt written notice of any material changes to the beneficial ownership information set out in Section 14
of the Perfection Certificate. Borrower understands and acknowledges that each Lender relies on such true, accurate and up-to-date beneficial
ownership information to meet such Lender’s regulatory obligations to obtain, verify and record information about the beneficial
owners of its legal entity customers;

 

(i) Legal
Action Notice. Prompt written notice of any legal actions, investigations or proceedings pending or threatened in writing against
Borrower or any of its Subsidiaries that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries
of, individually or in the aggregate, One Hundred Thousand Dollars ($100,000) or more;

 

(j) Tort
Claim Notice. If Borrower shall acquire a commercial tort claim, Borrower shall promptly notify Agent in a writing signed by Borrower
of the general details thereof and grant to Agent, for the ratable benefit of the Lenders, in such writing a security interest therein
and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory
to Agent;

 

(k) Government
Filings. Within five (5) days after the same are sent or received, copies of all correspondence, reports, documents and other filings
by Borrower or any of its Subsidiaries with any Governmental Authority regarding compliance with or maintenance of Governmental Approvals
or Applicable Law or that could reasonably be expected to have a material effect on any of the Governmental Approvals or otherwise on
the business of Borrower or any of its Subsidiaries;

 

(l) Registered
Organization. If Borrower is not a Registered Organization as of the Effective Date but later becomes one, promptly notify Agent
of such occurrence and provide Agent with Borrower’s organizational identification number;

 

(m)
Default. Prompt written notice upon knowledge of the occurrence of a Default or Event of Default; and

 

(n)
Other Financial Information. Other financial information reasonably requested by Agent or any Lender.

 

Any
submission by Borrower of a Compliance Statement or any other financial statement submitted to the Financial Statement Repository pursuant
to this Section 5.3 or otherwise submitted to Agent shall be deemed to be a representation by Borrower that (i) as of the date of such
Compliance Statement or other financial statement, the information and calculations set forth therein are true and correct, (ii) as of
the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except
as noted in such Compliance Statement or other financial statement, as applicable, (iii) as of the date of such submission, no Events
of Default have occurred or are continuing, (iv) all representations and warranties other than any representations or warranties that
are made as of a specific date in Section 4 remain true and correct in all material respects as of the date of such submission except
as noted in such Compliance Statement or other financial statement, as applicable, (v) as of the date of such submission, Borrower and
each of its Subsidiaries has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state
and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section
4.8, and (vi) as of the date of such submission, no Liens have been levied or claims made against Borrower or any of its Subsidiaries
relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Agent

 

    12

     

    

 

 5.4 Taxes; Pensions.

 

(a) Timely
file, and require each of its Subsidiaries to timely file (in each case, unless subject to a valid extension), all required tax returns
and reports and timely pay, and require each of its Subsidiaries to timely pay, all foreign, federal, state and local taxes, assessments,
deposits and contributions owed by Borrower and each of its Subsidiaries, except for deferred payment of any taxes contested pursuant
to the terms of Section 4.8(a) hereof, and shall deliver to Agent, on demand, appropriate certificates attesting to such payments, and
pay, and require each of its Subsidiaries to pay, all amounts necessary to fund all present pension, profit sharing and deferred compensation
plans in accordance with their terms.

 

(b)
To the extent Borrower or any of its Subsidiaries defers payment of any contested taxes, (i) notify Agent in writing of
the commencement of, and any material development in, the proceedings, and (ii) post bonds or take any other steps required to
prevent the Governmental Authority levying such contested taxes from obtaining a Lien upon any of the Collateral that is other than
a “Permitted Lien.”

 

 5.5 Access to Collateral; Books and Records. Allow Agent or its agents, at reasonable times, on five

 

(5) Business
Days’ notice (provided no notice is required if an Event of Default has occurred and is continuing), to inspect the Collateral
and audit and copy Borrower’s Books. Such inspections or audits shall be conducted no more often than once every twelve (12) months,
unless an Event of Default has occurred and is continuing, in which case such inspections and audits shall occur as often as Agent shall
determine is necessary. The foregoing inspections and audits shall be conducted at Borrower’s expense and the charge therefor shall
be One Thousand Dollars ($1,000.00) per person per day (or such higher amount as shall represent Agent’s then-current standard
charge for the same), plus out-of-pocket expenses. In the event Borrower and Agent schedule an audit more than eight (8) days in advance,
and Borrower cancels or seeks to or reschedules the audit with less than eight (8) days written notice to Agent, then (without limiting
any of Agent’s or any Lender’s rights or remedies) Borrower shall pay Agent a fee of Two Thousand Dollars ($2,000.00) plus
any out-of-pocket expenses incurred by Agent to compensate Agent for the anticipated costs and expenses of the cancellation or rescheduling.

 

 5.6 Insurance.

 

(a) Keep
its business and the Collateral insured for risks and in amounts standard for companies in Borrower’s industry and location and
as Agent may reasonably request. Insurance policies shall be in a form, with financially sound and reputable insurance companies that
are not Affiliates of Borrower, and in amounts that are satisfactory to Agent.

 

(b) All
property policies shall have a lender’s loss payable endorsement showing Agent as lender loss payee. All liability policies shall
show, or have endorsements showing, Agent as an additional insured. Agent shall be named as lender loss payee and/or additional insured
with respect to any such insurance providing coverage in respect of any Collateral.

 

(c) Ensure
that proceeds payable under any property policy are, at Agent’s option, payable to Agent for the ratable benefit of the Lenders
on account of the Obligations.

 

(d) At
Agent’s request, Borrower shall deliver certified copies of insurance policies and evidence of all premium payments. Each provider
of any such insurance required under this Section 5.6 shall agree, by endorsement upon the policy or policies issued by it or by independent
instruments furnished to Agent, that it will give Agent thirty (30) days prior written notice before any such policy or policies shall
be canceled or altered in any material respect. If Borrower fails to obtain insurance as required under this Section 5.6 or to pay any
amount or furnish any required proof of payment to third persons and Agent, Agent may make all or part of such payment or obtain such
insurance policies required in this Section 5.6, and take any action under the policies Agent deems prudent.

 

    13

     

    

 

 5.7 Operating Accounts.

 

(a) Subject
to the requirements set forth in Section 5.15, maintain all of Borrower’s, and any Guarantor’s operating accounts, depository
accounts and excess cash with SVB or SVB’s Affiliates.

 

(b) In
addition to the foregoing, Borrower, and any Guarantor, shall obtain any business credit card, letter of credit and cash management services
exclusively from SVB.

 

(c)
In addition to and without limiting the restrictions in (a), Borrower shall provide Agent five (5) days prior written
notice before establishing any Collateral Account at or with any bank or financial institution other than SVB or SVB’s
Affiliates. For each Collateral Account that Borrower at any time maintains, Borrower shall cause the applicable bank or financial
institution (other than SVB) at or with which any Collateral Account is maintained to execute and deliver a Control Agreement or
other appropriate instrument with respect to such Collateral Account to perfect Agent’s Lien in such Collateral Account in
accordance with the terms hereunder which Control Agreement may not be terminated without the prior written consent of the Lenders;
provided that no Control Agreement shall be required for Borrower’s accounts at CitiBank and UBS during the Transition Period
so long as Borrower is in compliance with Section 5.15 hereof. The provisions of the previous sentence shall not apply to deposit
accounts exclusively used for payroll, payroll taxes, and other employee wage and benefit payments to or for the benefit of
Borrower’s employees and identified to Agent and the Lenders by Borrower as such.

 

 5.8 Reserved.

 

 5.9 Protection of Intellectual Property Rights.

 

(a) (i)
Protect, defend and maintain the validity and enforceability of Borrower’s and each Subsidiary’s Intellectual Property, except
to the extent that such failure to do so would not reasonably be expected to have a material adverse effect on Borrower’s business
or operations; (ii) promptly advise Agent in writing of infringements or any other event that could reasonably be expected to materially
and adversely affect the value Borrower’s and each Subsidiary’s Intellectual Property; and (iii) not allow any Intellectual
Property material to Borrower’s or any Subsidiary’s business to be abandoned, forfeited or dedicated to the public without
Agent’s written consent.

 

(b) Provide
written notice to Agent within ten (10) days of entering or becoming bound by any Restricted License (other than over-the-counter software
that is commercially available to the public). Borrower shall take such steps as Agent requests to obtain the consent of, or waiver by,
any person whose consent or waiver is necessary for (i) any such Restricted License to be deemed “Collateral” and for Agent
to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License,
whether now existing or entered into in the future, and (ii) Agent to have the ability in the event of a liquidation of any Collateral
to dispose of such Collateral in accordance with Agent’s and the Lenders’ rights and remedies under this Agreement and the
other Loan Documents.

 

5.10
Litigation Cooperation. From the date hereof and continuing through the termination of this Agreement, make available to Agent, without
expense to Agent or any Lender, Borrower and its officers, employees and agents and Borrower’s books and records, to the extent
that Agent and/or the Lenders may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted
by or against Agent and/or any Lender with respect to any Collateral or relating to Borrower.

 

5.11
Formation or Acquisition of Subsidiaries. Notwithstanding and without limiting the negative covenants contained in Sections 6.3 and
6.7 hereof, at the time that Borrower or any Guarantor forms any Subsidiary or acquires any Subsidiary after the Effective Date (including,
without limitation, pursuant to a Division), Borrower and such Guarantor shall (a) cause such new Subsidiary to provide to Lenders a
joinder to this Agreement to become a co-borrower hereunder or a guaranty to become a Guarantor hereunder (as determined by Agent in
its sole discretion), together with documentation, all in form and substance satisfactory to Agent and Lenders (including being sufficient
to grant Lenders a first priority Lien (subject to Permitted Liens) in and to the assets of such newly formed or acquired Subsidiary),
(b) provide to Lenders appropriate certificates and powers and financing statements, pledging all of the direct or beneficial ownership
interest in such new Subsidiary, in form and substance satisfactory to Agent and Lenders; and (c) provide to Lenders all other documentation
in form and substance satisfactory to Agent and Lenders, including one or more opinions of counsel satisfactory to Lenders, which in
its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above. Any document,
agreement, or instrument executed or issued pursuant to this Section 5.11 shall be a Loan Document.

 

    14

     

    

 

5.12
Inventory; Returns. Keep all Inventory in good and marketable condition, free from material defects. Returns and allowances between
Borrower and its Account Debtors shall follow Borrower’s customary practices as they exist at the Effective Date. Borrower shall
promptly notify Agent and the Lenders of all returns, recoveries, disputes and claims that involve more than One Hundred Thousand Dollars
($100,000.00).

 

5.13
Further Assurances. Execute any further instruments and take such further action as Agent and the Lenders reasonably request to perfect,
protect, ensure the priority of or continue Agent’s Lien on the Collateral or to effect the purposes of this Agreement.

 

5.14
Sanctions. (a) Not, and not permit any of its Subsidiaries to, engage in any of the activities described in Section 4.9 in the future;
(b) not, and not permit any of its Subsidiaries to, become a Sanctioned Person;

(c) ensure
that the proceeds of the Obligations are not used to violate any Sanctions; and (d) deliver to Agent any certification or other evidence
requested from time to time by Agent in its sole discretion, confirming each such Person’s compliance with this Section 5.14. In
addition, have implemented, and will consistently apply while this Agreement is in effect, procedures to ensure that the representations
and warranties in Section 4.9 remain true and correct while this Agreement is in effect.

 

5.15
Post-Closing Matters. (a) Deliver to Agent, within sixty (60) days of the Moving Date, a landlord’s consent for the
location of Borrower’s new headquarter in favor of Agent, by each such third party, together with the duly executed signatures
thereto, in form and substance acceptable to Agent and the Lenders. (b) Within forty-five (45) days following the
Effective Date (such period, the “Transition Period”), Borrower shall close its Deposit Accounts maintained at CitiBank
and UBS and transfer all proceeds in such account to one or more Deposit Accounts of Borrower maintained at Agent; provided,
that during the Transition Period, Borrower shall maintain at least Thirty Million Dollars ($30,000,000) in aggregate in operating
accounts, depository accounts and in excess cash with SVB or SVB’s Affiliates. (c) Within thirty (30) days following the
Effective Date, Borrower shall deliver to Agent evidence satisfactory to Agent that the insurance policies and endorsements required
by Section 5.6 hereof are in full force and effect with respect to Borrower, together with appropriate evidence showing lender loss
payable and additional insured clauses or endorsements in favor of Agent.

 

 6 NEGATIVE COVENANTS

 

Borrower
shall not do any of the following without the prior written consent of the Lenders:

 

6.1
Dispositions. Convey, sell, lease, transfer, assign, or otherwise dispose of (including, without limitation, pursuant to a Division)
(collectively, a “Transfer”), or permit any of its Subsidiaries to Transfer, all or any part of its business or property,
except for Transfers (a) of Inventory in the ordinary course of business; (b) of worn-out or obsolete Equipment that is, in the reasonable
judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of business of Borrower; (c) consisting
of Permitted Liens and Permitted Investments; (d) consisting of the sale or issuance of any stock, partnership, membership, or other
ownership interest or other equity securities of Borrower permitted under Section 6.2 of this Agreement; (e) consisting of Borrower’s
or its Subsidiaries’ use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement
or the other Loan Documents; and (f) of non-exclusive licenses for the use of the property of Borrower or its Subsidiaries in the ordinary
course of business.

 

6.2
Changes in Business, Management, Control, or Business Locations. (a) Engage in or permit any of its Subsidiaries to engage in any
business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto;
(b) liquidate or dissolve or permit any of its Subsidiaries to liquidate or dissolve; (c) fail to provide notice to Agent and Lenders
of any Key Person departing from or ceasing to be employed by Borrower within ten (10) Business Days after such Key Person’s departure
from Borrower; (d) permit, allow or suffer to occur any Change in Control; or (e) without at least thirty (30) days prior written notice
to Agent, (i) add any new offices or business locations, including warehouses (unless such new offices or business locations contain
less than One-Hundred Thousand Dollars ($100,000) in Borrower’s assets or property) or deliver any portion of the Collateral valued,
individually or in the aggregate, in excess of One-Hundred Thousand Dollars ($100,000) to a bailee at a location other than to a bailee
and at a location already disclosed in the Perfection Certificate, (ii) change its jurisdiction of organization, (iii) change its organizational
structure or type, (iv) change its legal name, or (v) change any organizational number (if any) assigned by its jurisdiction of organization.
If Borrower intends to add any new offices or business locations, including warehouses, containing in excess of One-Hundred Thousand
Dollars ($100,000) of Borrower’s assets or property, then Borrower will cause the landlord of any such new offices or business
locations, including warehouses, to execute and deliver a landlord consent in form and substance satisfactory to Agent. If Borrower intends
to deliver any portion of the Collateral valued, individually or in the aggregate, in excess of One-Hundred Thousand Dollars ($100,000)
to a bailee, and Agent and such bailee are not already parties to a bailee agreement governing both the Collateral and the location to
which Borrower intends to deliver the Collateral, then Borrower will cause such bailee to execute and deliver a bailee agreement in form
and substance satisfactory to Agent. Borrower shall not effect or permit any of the above-mentioned changes unless all filings have been
made and all other actions taken that are required in order for Agent to continue at all times following such change to have a valid
and perfected first priority Lien with respect to all of the Collateral.

 

    15

     

    

 

6.3
Mergers, Amalgamations or Acquisitions. Merge, amalgamate, or consolidate, or permit any of its Subsidiaries to merge, amalgamate
or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the stock,
partnership, membership, or other ownership interest or other equity securities or property of another Person (including, without limitation,
by the formation of any Subsidiary or pursuant to a Division),other than Permitted Acquisitions. A Subsidiary may merge or consolidate
into another Subsidiary or into Borrower.

 

6.4
Indebtedness. Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness.

 

6.5
Encumbrance. Create, incur, allow, or suffer to exist any Lien on any of its property, or assign or convey any right to receive income,
including the sale of any Accounts, or permit any of its Subsidiaries to do so, except for Permitted Liens, permit any Collateral not
to be subject to the first priority security interest granted herein, or enter into any agreement, document, instrument or other arrangement
(except with or in favor of Agent, for the ratable benefit of the Lenders) with any Person which directly or indirectly prohibits or
has the effect of prohibiting Borrower or any Subsidiary from assigning, mortgaging, pledging, granting a security interest in or upon,
or encumbering any of Borrower’s or any Subsidiary’s Intellectual Property, except as is otherwise permitted in Section 6.1
hereof and the definition of “Permitted Liens” herein.

 

6.6
Maintenance of Collateral Accounts. Maintain any Collateral Account except pursuant to the terms of Section 5.7(c).

 

6.7
Distributions; Investments. (a) Pay any dividends or make any distribution or payment or redeem, retire or purchase any stock, partnership,
membership, or other ownership interest or other equity securities provided that Borrower may (i) convert any of its convertible securities
into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii) pay dividends solely
in common stock, and (iii) repurchase the stock, partnership, membership, or other ownership interest or other equity securities of former
employees or consultants pursuant to stock repurchase agreements so long as an Event of Default does not exist at the time of any such
repurchase and would not exist after giving effect to any such repurchase, provided that the aggregate amount of all such repurchases
does not exceed One Hundred Thousand Dollars ($100,00) per fiscal year; or (b) directly or indirectly make any Investment (including,
without limitation, by the formation of any Subsidiary) other than Permitted Investments, or permit any of its Subsidiaries to do so.

 

6.8
Transactions with Affiliates. Directly or indirectly enter into or permit to exist any material transaction with any Affiliate of
Borrower, except for transactions that are in the ordinary course of Borrower’s business, upon fair and reasonable terms that are
no less favorable to Borrower than would be obtained in an arm’s length transaction with a non-affiliated Person.

 

6.9
Subordinated Debt. Except as expressly permitted under the terms of the subordination, intercreditor, or other similar agreement
to which any Subordinated Debt is subject: (a) make or permit any payment on such Subordinated Debt; or (b) amend any provision in any
document relating to such Subordinated Debt which would increase the amount thereof, provide for earlier or greater principal, interest,
or other payments thereon, or adversely affect the subordination thereof to Obligations owed to Agent and the Lenders.

 

    16

     

    

 

6.10
Compliance. (a) Become an “investment company” or a company controlled by an “investment company”, under
the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry
margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Credit
Extension for that purpose; (b)(i) fail to meet the minimum funding requirements of ERISA, (ii) permit a Reportable Event or Prohibited
Transaction, as defined in ERISA, to occur, (iii) fail to comply with the Federal Fair Labor Standards Act or (iv) violate any other
law or regulation, if the foregoing subclauses (i) through (iv), individually or in the aggregate, could reasonably be expected to have
a material adverse effect on Borrower’s business or operations, or permit any of its Subsidiaries to do so; or (c) withdraw or
permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the occurrence of any other
event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result
in any liability of Borrower, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental
Authority.

 

6.11
Subsidiary Assets. Permit the aggregate value of assets held by any Subsidiaries of Borrower that are not either co-Borrowers or
secured Guarantors hereunder to exceed Five Hundred Thousand Dollars ($500,000) (or equivalent) in the aggregate for all such Subsidiaries
at any time (the “Subsidiary Asset Cap”); provided, however, that such Subsidiaries may exceed the Subsidiary Asset Cap as
the result of ordinary course cash transfers to pay vendors and for research and development expenses so long as the Subsidiary Asset
Cap is not exceeded for more than five (5) consecutive Business Days.

 

 7 EVENTS OF DEFAULT

 

Any
one of the following shall constitute an event of default (an “Event of Default”) under this Agreement:

 

7.1
Payment Default. Borrower fails to (a) make any payment of principal or interest on any Credit Extension on its due date, or (b)
pay any other Obligations within five (5) Business Days after such Obligations are due and payable (which three (3) Business Day cure
period shall not apply to payments due on the Term Loan Maturity Date). During the cure period, the failure to make or pay any payment
specified under clause (b) hereunder is not an Event of Default (but no Credit Extension will be made during the cure period);

 

 7.2 Covenant Default.

 

(a) Borrower
fails or neglects to perform any obligation in Section 5 (other than Sections 5.2 (Government Compliance), 5.10 (Litigation Cooperation),
5.13 (Inventory; Returns) and 5.14 (Further Assurances)) or violates any covenant in Section 6; or

 

(b) Borrower
fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this
Agreement or any Loan Documents, and as to any default (other than those specified in this Section 7) under such other term,
provision, condition, covenant or agreement that can be cured, has failed to cure the default within fifteen (15) days after notice
or knowledge of the occurrence thereof; provided, however, that if the default cannot by its nature be cured within the fifteen (15)
day period or cannot after diligent attempts by Borrower be cured within such fifteen (15) day period, and such default is likely to
be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed forty five (45) days)
to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event
of Default (but no Credit Extensions shall be made during such cure period). Cure periods provided under this section shall not
apply, among other things, to financial covenants or any other covenants that are required to be satisfied, completed or tested by a
date certain or any covenants set forth in clause (a) above;

 

 7.3 Material Adverse Change. A Material Adverse Change occurs;

 

    17

     

    

 

 7.4 Attachment; Levy; Restraint on Business.

 

(a) (i)
The service of process seeking to attach, by trustee or similar process, any funds of Borrower or any Subsidiary, or (ii) a notice of
lien or levy is filed against any of Borrower’s or any of its Subsidiaries’ assets by any Governmental Authority, and the
same under subclauses (i) and (ii) hereof are not, within ten (10) days after the occurrence thereof, discharged or stayed (whether through
the posting of a bond or otherwise); provided, however, no Credit Extensions shall be made during any fifteen (15) day cure period; or

 

(b) (i)
any material portion of Borrower’s or any of its Subsidiaries’ assets is attached, seized, levied on, or comes into possession
of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents Borrower or any of its Subsidiaries from conducting
all or any material part of its business;

 

7.5
Insolvency. (a) Borrower or any of its Subsidiaries is unable to pay its debts (including trade debts) as they become due or otherwise
becomes insolvent; (b) Borrower or any of its Subsidiaries begins an Insolvency Proceeding; or (c) an Insolvency Proceeding is begun
against Borrower or any of its Subsidiaries and is not dismissed or stayed within thirty (30) days (but no Credit Extensions shall be
made while any of the conditions described in clause (a) exist or until any Insolvency Proceeding is dismissed);

 

7.6
Other Agreements. There is, under any agreement to which Borrower, any of Borrower’s Subsidiaries, or any Guarantor is a party
with a third party or parties, (a) any default resulting in a right by such third party or parties, whether or not exercised, to accelerate
the maturity of any Indebtedness in an amount individually or in the aggregate in excess of One Hundred Thousand Dollars ($100,000);
or (b) any breach or default by Borrower, any of Borrower’s Subsidiaries, or Guarantor, the result of which could have a material
adverse effect on Borrower’s, any of Borrower’s Subsidiaries’, or any Guarantor’s business or operations;

 

7.7
Judgments; Penalties. One or more fines, penalties or final judgments, orders or decrees for the payment of money in an amount, individually
or in the aggregate, of at least Two Hundred Thousand Dollars ($200,000) (not covered by independent third-party insurance as to which
liability has been accepted by such insurance carrier) shall be rendered against Borrower or any of its Subsidiaries by any Governmental
Authority, and the same are not, within fifteen (15) days after the entry, assessment or issuance thereof, discharged, or after execution
thereof, or stayed pending appeal, or such judgments are not discharged prior to the expiration of any such stay (provided that no Credit
Extensions will be made prior to the discharge, or stay of such fine, penalty, judgment, order or decree);

 

7.8
Misrepresentations. Borrower or any of its Subsidiaries or any Person acting for Borrower or any of its Subsidiaries makes any representation,
warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Agent or any Lender or
to induce Agent or any Lender to enter this Agreement or any Loan Document, and such representation, warranty, or other statement is
incorrect in any material respect when made (it being agreed and acknowledged by Agent and each Lender that the projections and forecasts
provided by Borrower or any of its Subsidiaries in good faith and based upon reasonable assumptions are not viewed as facts and that
actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results);

 

7.9
Subordinated Debt. If: (a) any document, instrument, or agreement evidencing any Subordinated Debt shall for any reason be revoked
or invalidated or otherwise cease to be in full force and effect, or any Person (other than SVB) shall be in breach thereof or contest
in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder; (b) a default
or event of default (however defined) has occurred under any document, instrument, or agreement evidencing any Subordinated Debt, which
default shall not have been cured or waived within any applicable grace period; or (c) the Obligations shall for any reason be subordinated
or shall not have the priority contemplated by this Agreement or any applicable subordination or intercreditor agreement;

 

7.10
Lien Priority. There is a material impairment in the perfection or priority of Agent’s security interest in the Collateral;

 

7.11
Guaranty. (a) Any guaranty of any Obligations terminates or ceases for any reason to be in full force and effect; (b) any
Guarantor does not perform any obligation or covenant under any guaranty of the Obligations; (c) any circumstance described in
Sections 7.3, 7.4, 7.5, 7.6, 7.7, or 7.8 of this Agreement occurs with respect to any Guarantor, (d) the death, liquidation, winding
up, or termination of existence of any Guarantor; or (e)(i) a material impairment in the perfection or priority of Agent’s
Lien in the collateral provided by Guarantor or in the value of such collateral or (ii) a material adverse change in the general
affairs, management, results of operation, condition (financial or otherwise) or the prospect of repayment of the Obligations occurs
with respect to any Guarantor; or

 

    18

     

    

 

7.12
Governmental Approvals. Any Governmental Approval shall have been (a) revoked, rescinded, suspended, modified in an adverse manner
or not renewed in the ordinary course for a full term or (b) subject to any decision by a Governmental Authority that designates a hearing
with respect to any applications for renewal of any of such Governmental Approval or that could result in the Governmental Authority
taking any of the actions described in clause (a) above, and such decision or such revocation, rescission, suspension, modification or
non-renewal (i) causes, or could reasonably be expected to cause, a Material Adverse Change, or (ii) adversely affects the legal qualifications
of Borrower or any of its Subsidiaries to hold such Governmental Approval in any applicable jurisdiction and such revocation, rescission,
suspension, modification or non-renewal could reasonably be expected to affect the status of or legal qualifications of Borrower or any
of its Subsidiaries to hold any Governmental Approval in any other jurisdiction.

 

7.13
Delisting. Shares of Borrower’s common stock are delisted from the NASDAQ because of Borrower’s failure to comply with
continued listing standards thereof or due to a voluntary delisting which results in such shares not being listed on such exchange or
market.

 

 8 RIGHTS AND REMEDIES

 

8.1
Rights and Remedies. Upon the occurrence and during the continuance of an Event of Default, Agent, as directed by Lenders in accordance
with the Lender Intercreditor Agreement or, if such rights and remedies are not addressed in the Lender Intercreditor Agreement, as directed
by Lenders having a majority of the Obligations, may, without notice or demand, do any or all of the following:

 

(a) declare
all Obligations immediately due and payable (but if an Event of Default described in Section 7.5 occurs all Obligations are immediately
due and payable without any action by Agent or any Lender);

 

(b) stop
advancing money or extending credit for Borrower’s benefit under this Agreement or under any other agreement among Borrower, Agent
and/or any Lenders;

 

(c) demand
that Borrower (i) deposit cash with SVB in an amount equal to at least (A) one hundred five percent (105.0%) of the aggregate face amount
of any Letters of Credit denominated in Dollars remaining undrawn, and (B) one hundred fifteen percent (115.0%) of the Dollar Equivalent
of the aggregate face amount of any Letters of Credit denominated in a Foreign Currency remaining undrawn (plus, in each case, all interest,
fees, and costs due or estimated by SVB to become due in connection therewith), to secure all of the Obligations relating to such Letters
of Credit, as collateral security for the repayment of any future drawings under such Letters of Credit, and Borrower shall forthwith
deposit and pay such amounts, and (ii) pay in advance all letter of credit fees scheduled to be paid or payable over the remaining term
of any Letters of Credit;

 

(d) terminate
any FX Contracts (it being understood and agreed that (i) SVB is not obligated to deliver the currency which Borrower has contracted
to receive under any FX Contract, and SVB may cover its exposure for any FX Contracts by purchasing or selling currency in the
interbank market as SVB deems appropriate; (ii) Borrower shall be liable for all losses, damages, costs, margin obligations and
expenses incurred by SVB arising from Borrower’s failure to satisfy its obligations under any FX Contract or the execution of
any FX Contract; and (iii) SVB shall not be liable to Borrower for any gain in value of a FX Contract that SVB may obtain in
covering Borrower’s breach);

 

(e) verify
the amount of, demand payment of and performance under, and collect any Accounts and General Intangibles, settle or adjust disputes and
claims directly with Account Debtors for amounts on terms and in any order that Agent and/or the Lenders consider advisable, and notify
any Person owing Borrower money of Agent’s security interest in such funds;

 

(f) make
any payments and do any acts Agent or any Lender considers necessary or reasonable to protect the Collateral and/or its security interest
in the Collateral. Borrower shall assemble the Collateral if Agent requests and make it available as Agent designates. Agent may enter
premises where the Collateral is located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or
compromise any Lien which appears to be prior or superior to its security interest and pay all expenses incurred. Borrower grants Agent
a license to enter and occupy any of its premises, without charge, to exercise any of Agent’s rights or remedies;

 

    19

     

    

 

(g) apply
to the Obligations any (i) balances and deposits of Borrower it holds, or (ii) any amount held by Agent owing to or for the credit or
the account of Borrower;

 

(h) ship,
reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell the Collateral. For use solely upon
the occurrence and during the continuation of an Event of Default, Agent, for the benefit of the Lenders, is hereby granted a non-exclusive,
royalty-free license or other right to use, without charge, Borrower’s labels, Patents, Copyrights, mask works, rights of use of
any name, trade secrets, trade names, Trademarks, and advertising matter, or any similar property as it pertains to the Collateral, in
completing production of, advertising for sale, and selling any Collateral and, in connection with Agent’s exercise of its rights
under this Section 8.1, Borrower’s rights under all licenses and all franchise agreements inure to Agent, for the ratable benefit
of the Lenders;

 

(i) place
a “hold” on any account maintained with Agent or Lenders and/or deliver a notice of exclusive control, any entitlement order,
or other directions or instructions pursuant to any Control Agreement or similar agreements providing control of any Collateral;

 

 (j) demand and receive possession of Borrower’s Books;

 

(k) appoint
by instrument in writing one or more Receivers of any Borrower or Guarantor or any or all of the Collateral with such rights, powers
and authority (including any or all of the rights, powers and authority of Agent or any Lender under this Agreement) as may be provided
for in the instrument of appointment or any supplemental instrument, and remove and replace any such Receiver from time to time. To the
extent permitted by applicable law, any Receiver appointed by Agent shall (for purposes relating to responsibility for the Receiver's
acts or omissions) be considered to be the agent of the applicable Borrower/Guarantor and not of Agent or any Lender;

 

(l) obtain
from any court of competent jurisdiction an order for the appointment of a Receiver of any Borrower/Guarantor or for the sale or foreclosure
of any or all of the Collateral;

 

(m) realize
on any or all of the Collateral and sell, lease, assign, give options to purchase, or otherwise dispose of and deliver any or all of
the Collateral (or contract to do any of the above), in one or more parcels at any public or private sale, on such terms and conditions
as Agent may deem advisable and at such prices as it may deem best; and

 

(n) exercise
all rights and remedies available to Agent and the Lenders under the Loan Documents or at law or equity, including all remedies provided
under the Code or any Applicable Law (including disposal of the Collateral pursuant to the terms thereof).

 

8.2
Power of Attorney. Borrower hereby irrevocably appoints Agent, for the benefit of the Lenders, as its true and lawful
attorney-in-fact, (a) exercisable upon the occurrence and during the continuance of an Event of Default, to: (i) endorse
Borrower’s name on any checks, payment instruments, or other forms of payment or security; (ii) sign
Borrower’s name on any invoice or bill of lading for any Account or drafts against Account Debtors; (iii) demand, collect,
sue, and give releases to any Account Debtor for monies due, settle and adjust disputes and claims about the Accounts directly with
Account Debtors, and compromise, prosecute, or defend any action, claim, case, or proceeding about any Collateral (including filing
a claim or voting a claim in any bankruptcy case in Agent’s or Borrower’s name, as Agent chooses); (iv) make, settle,
and adjust all claims under Borrower’s insurance policies; (v) pay, contest or settle any Lien, charge, encumbrance, security
interest, and adverse claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or
discharge the same; and (vi) transfer the Collateral into the name of Agent or a third party as the Code permits; and (b) regardless
of whether an Event of Default has occurred, to sign Borrower’s name on any documents necessary to perfect or continue the
perfection of Agent’s security interest in the Collateral. Agent’s foregoing appointment as Borrower’s attorney in
fact, and all of Agent’s rights and powers, coupled with an interest, are irrevocable until such time as all Obligations
(other than inchoate indemnity obligations) have been satisfied in full, Agent is under no further obligation to make Credit
Extensions and the Loan Documents have been terminated. Agent shall not incur any liability in connection with or arising from the
exercise of such power of attorney and shall have no obligation to exercise any of the foregoing rights and remedies.

 

    20

     

    

 

8.3
Protective Payments. If Borrower fails to obtain the insurance called for by Section 5.6 or fails to pay any premium thereon or fails
to pay any other amount which Borrower is obligated to pay under this Agreement or any other Loan Document or which may be required to
preserve the Collateral, Agent may obtain such insurance or make such payment, and all amounts so paid by Agent are Lenders’ Expenses
and immediately due and payable, bearing interest at the then highest rate applicable to the Obligations, and secured by the Collateral.
Agent will make reasonable efforts to provide Borrower with notice of Agent obtaining such insurance at the time it is obtained or within
a reasonable time thereafter. No payments by Agent are deemed an agreement to make similar payments in the future or Agent’s or
any Lender’s waiver of any Event of Default.

 

8.4
Application of Payments and Proceeds. Agent may apply any funds in its possession, whether from Borrower account balances, payments,
proceeds realized as the result of any collection of Accounts or other disposition of the Collateral, or otherwise, to the Obligations
in such order as Agent shall determine in its sole discretion. Any surplus shall be paid to Borrower or other Persons legally entitled
thereto; Borrower shall remain liable to Agent and the Lenders for any deficiency. If Agent, in its commercially reasonable discretion,
directly or indirectly, enters into a deferred payment or other credit transaction with any purchaser at any sale of Collateral, Agent
shall have the option, exercisable at any time, of either reducing the Obligations by the principal amount of the purchase price or deferring
the reduction of the Obligations until the actual receipt by Agent of cash therefor.

 

8.5
Liability for Collateral. Agent’s and Lenders’ sole duty with respect to the custody, safekeeping and physical preservation
of the Collateral in their possession or under the control of Agent and/or Lenders, under Section 9-207 of the Code or otherwise, shall
be to deal with it in the same manner as Agent and/or Lenders deal with their own property consisting of similar instruments or interests.
Borrower bears all risk of loss, damage or destruction of the Collateral.

 

8.6
No Waiver; Remedies Cumulative. Agent’s and any Lender’s failure, at any time or times, to require strict performance
by Borrower of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Agent or
any Lender thereafter to demand strict performance and compliance herewith or therewith. No waiver hereunder shall be effective unless
signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given. Agent’s
and each Lender’s rights and remedies under this Agreement and the other Loan Documents are cumulative. Agent and each Lender have
all rights and remedies provided under the Code, by law, or in equity. Agent’s or any Lender’s exercise of one right or remedy
is not an election and shall not preclude Agent or any Lender from exercising any other remedy under this Agreement or other remedy available
at law or in equity, and Agent’s or any Lender’s waiver of any Event of Default is not a continuing waiver. Agent’s
or any Lender’s delay in exercising any remedy is not a waiver, election, or acquiescence.

 

8.7
Demand Waiver. Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment
at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees
held by Agent on which Borrower is liable.

 

 9 AGENT

 

 9.1 Appointment and Authority.

 

(a) Each
Lender hereby irrevocably appoints SVB to act on its behalf as Agent hereunder and under the other Loan Documents and authorizes Agent
to take such actions on its behalf and to exercise such powers as are delegated to Agent by the terms hereof or thereof, together with
such actions and powers as are reasonably incidental thereto.

 

    21

     

    

 

(b) The
provisions of this Section 9 are solely for the benefit of Agent and Lenders, and Borrower shall not have rights as a third-party beneficiary
of any of such provisions. Notwithstanding any provision to the contrary elsewhere in this Agreement, Agent shall not have any duties
or responsibilities to any Lender or any other Person, except those expressly set forth herein, or any fiduciary relationship with any
Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or
any other Loan Document or otherwise exist against Agent.

 

9.2
Delegation of Duties. Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other
Loan Document by or through any one or more sub-agents appointed by Agent. Agent and any such sub-agent may perform any and all of its
duties and exercise its rights and powers by or through their respective Indemnified Persons. The exculpatory provisions of this Section
9.2 shall apply to any such sub-agent and to the Indemnified Persons of Agent and any such sub-agent, and shall apply to their respective
activities in connection with the syndication of the credit facilities provided for herein as well as activities as Agent.

 

9.3
Exculpatory Provisions. Agent shall have no duties or obligations except those expressly set forth herein and in the other Loan Documents.
Without limiting the generality of the foregoing, Agent shall not:

 

(a) be
subject to any fiduciary, trust, agency or other similar duties, regardless of whether any Event of Default has occurred and is continuing;

 

(b) have
any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated
hereby or by the other Loan Documents that Agent is required to exercise as directed in writing by the Lenders, as applicable; provided
that Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose Agent to liability
or that is contrary to any Loan Document or applicable law; and

 

(c) except
as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and Agent shall not be liable for the failure
to disclose, any information relating to Borrower or any of its Affiliates that is communicated to or obtained by any Person serving
as Agent or any of its Affiliates in any capacity.

 

Agent
shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the Lenders (or as Agent shall
believe in good faith shall be necessary, under the circumstances as provided in Section 12.7) or (ii) in the absence of its own gross
negligence or willful misconduct.

 

Agent
shall not be responsible for or have any duty to ascertain or inquire into (A) any statement, warranty or representation made in or in
connection with this Agreement or any other Loan Document, (B) the contents of any certificate, report or other document delivered hereunder
or thereunder or in connection herewith or therewith, (C) the performance or observance of any of the covenants, agreements or other
terms or conditions set forth herein or therein or the occurrence of any Event of Default, (D) the validity, enforceability, effectiveness
or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (E) the satisfaction of any
condition set forth in Section 3 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to Agent.

 

9.4
Reliance by Agent. Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request,
certificate, consent, statement, instrument, document or other writing (including any electronic message, internet or intranet website
posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person.
Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and
shall not incur any liability for relying thereon. Agent may consult with legal counsel (who may be counsel for Borrower), independent
accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the
advice of any such counsel, accountants or experts. In determining compliance with any condition hereunder to the making of a Credit
Extension that, by its terms, must be fulfilled to the satisfaction of a Lender, Agent may presume that such condition is satisfactory
to such Lender unless Agent shall have received notice to the contrary from such Lender prior to the making of such Credit Extension.
Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents
in accordance with a request of the Lenders, and such request and any action taken or failure to act pursuant thereto shall be binding
upon Lenders and all future holders of the Credit Extensions.

 

    22

     

    

 

9.5
Notice of Default. Agent shall not be deemed to have knowledge or notice of the occurrence of any Event of Default (except with respect
to defaults in the payment of principal, interest or fees required to be paid to Agent for the account of Lenders), unless Agent has
received notice from a Lender or Borrower referring to this Agreement, describing such Event of Default and stating that such notice
is a “notice of default”. In the event that Agent receives such a notice, Agent shall give notice thereof to Lenders. Agent
shall take such action with respect to such Event of Default as shall be reasonably directed by the Lenders.

 

9.6
Non-Reliance on Agent and Other Lenders. Each Lender expressly acknowledges that neither Agent nor any of its officers, directors,
employees, agents, attorneys in fact or affiliates has made any representations or warranties to it and that no act by Agent hereafter
taken, including any review of the affairs of a Group Member or any Affiliate of a Group Member, shall be deemed to constitute any representation
or warranty by Agent to any Lender. Each Lender represents to Agent that it has, independently and without reliance upon Agent or any
other Lender, and based on such documents and information as it has deemed appropriate, made its own appraisal of, and investigation
into, the business, operations, property, financial and other condition and creditworthiness of the Group Members and their Affiliates
and made its own decision to make its Credit Extensions hereunder and enter into this Agreement. Each Lender also represents that it
will, independently and without reliance upon Agent or any other Lender, and based on such documents and information as it shall deem
appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this
Agreement and the other Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations,
property, financial and other condition and creditworthiness of the Group Members and their Affiliates. Except for notices, reports and
other documents expressly required to be furnished to Lenders by Agent hereunder, Agent shall have no duty or responsibility to provide
any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects
or creditworthiness of any Group Member or any Affiliate of a Group Member that may come into the possession of Agent or any of its officers,
directors, employees, agents, attorneys in fact or Affiliates.

 

9.7
Indemnification. Each Lender agrees to indemnify Agent in its capacity as such (to the extent not reimbursed by Borrower and without
limiting the obligation of Borrower to do so in accordance with the terms hereof, according to its Term Loan Commitment Percentage in
effect on the date on which indemnification is sought under this Section 9.7 (or, if indemnification is sought after the date upon which
the Commitments shall have terminated and the Obligations shall have been paid in full, in accordance with its Term Loan Commitment Percentage
immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments,
suits, costs, expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Credit
Extensions) be imposed on, incurred by or asserted against Agent in any way relating to or arising out of, the Commitments, this Agreement,
any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby
or thereby or any action taken or omitted by Agent under or in connection with any of the foregoing; provided that no Lender shall
be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs,
expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted
primarily from Agent’s gross negligence or willful misconduct. The agreements in this Section shall survive the payment of the
Credit Extensions and all other amounts payable hereunder.

 

9.8
Agent in Its Individual Capacity. The Person serving as Agent hereunder shall have the same rights and powers in its capacity as
a Lender as any other Lender and may exercise the same as though it were not Agent and the term “Lender” or “Lenders”
shall, unless otherwise expressly indicated or unless the context otherwise requires, include each such Person serving as Agent hereunder
in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, act as the financial advisor or in
any other advisory capacity for and generally engage in any kind of business with Borrower, any Guarantor or any Subsidiary or other
Affiliate thereof as if such Person were not Agent hereunder and without any duty to account therefor to Lenders.

 

    23

     

    

 

9.9
Successor Agent. Agent may at any time give notice of its resignation to Lenders and Borrower, which resignation shall not be
effective until the time at which the majority of the Lenders have delivered to Agent their written consent to such resignation.
Upon receipt of any such notice of resignation, the Lenders shall have the right, in consultation with Borrower, to appoint a
successor, which shall be a financial institution with an office in the State of California, or an Affiliate of any such bank with
an office in the State of California. If no such successor shall have been so appointed by the Lenders and shall have accepted such
appointment within thirty (30) days after the retiring Agent has received the written consent of the majority of the Lenders to such
resignation, then the retiring Agent may on behalf of Lenders, appoint a successor Agent meeting the qualifications set forth above;
provided that in no event shall any such successor Agent be a Defaulting Lender and provided further that if the retiring Agent
shall notify Borrower and Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless
become effective in accordance with such notice and (1) the retiring Agent shall be discharged from its duties and obligations
hereunder and under the other Loan Documents (except that in the case of any collateral security held by Agent on behalf of the
Lenders under any of the Loan Documents, the retiring Agent shall continue to hold such collateral security until such time as a
successor Agent is appointed and such collateral security is assigned to such successor Agent) and (2) all payments, communications
and determinations provided to be made by, to or through Agent shall instead be made by or to each Lender directly, until such time
as the Lenders appoint a successor Agent as provided for above in this Section 9.9. Upon the acceptance of a successor’s
appointment as Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and
duties of the retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and obligations
hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section 9.9). The fees
payable by Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between
Borrower and such successor. After the retiring Agent’s resignation hereunder and under the other Loan Documents, the
provisions of this Section 9 shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective
Indemnified Persons in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting as
Agent.

 

 9.10 Defaulting Lender.

 

(a) Defaulting
Lender Adjustments. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender,
then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law:

 

(i) Waivers
and Amendments. Such Defaulting Lender’s right to approve or disapprove any amendment, waiver or consent with respect to this
Agreement shall be restricted as long as said Lender is a Defaulting Lender.

 

(ii) Defaulting
Lender Waterfall. Any payment of principal, interest, fees or other amounts received by the Agent for the account of such Defaulting
Lender (whether voluntary or mandatory, at maturity, pursuant to Section 7 or otherwise, and including any amounts made available to
the Agent by such Defaulting Lender pursuant to Section 12.10), shall be applied at such time or times as may be determined by the Agent
as follows: first, to the payment of any amounts owing by such Defaulting Lender to the Agent hereunder; second, as Borrower
may request (so long as no Event of Default exists), to the funding of any Term Loan Advance in respect of which such Defaulting Lender
has failed to fund its portion thereof as required by this Agreement, as determined by the Agent; third, if so determined by the
Agent and Borrower, to be held in a Deposit Account and released pro rata to satisfy such Defaulting Lender’s potential future
funding obligations with respect to Term Loan Advances under this Agreement; fourth, so long as no Event of Default has occurred
and is continuing, to the payment of any amounts owing to Borrower as a result of any judgment of a court of competent jurisdiction obtained
by Borrower against such Defaulting Lender as a result of such Defaulting Lender’s breach of its obligations under this Agreement;
and fifth, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction; provided that if (A)
such payment is a payment of the principal amount of any Term Loan Advances in respect of which such Defaulting Lender has not fully
funded its appropriate share and (B) such Term Loan Advances were made at a time when the conditions set forth in Section 2.1 were satisfied
or waived, such payment shall be applied solely to pay the Term Loan Advance of all non-Defaulting Lenders on a pro rata basis
prior to being applied to the payment of any Term Loan Advances of such Defaulting Lender until such time as all Term Loan Advances are
held by the Lenders pro rata in accordance with the Term Loan Commitments under this Agreement. Any payments, prepayments or other amounts
paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender pursuant to this Section
9.10(a)(ii) shall be deemed paid to and redirected by such Defaulting Lender, and each Lender irrevocably consents hereto.

 

    24

     

    

 

(iii) Certain
Fees. No Defaulting Lender shall be entitled to receive any fee pursuant to Section 1.3(b) for any period during which such Lender
is a Defaulting Lender (and Borrower shall not be required to pay any such fee that otherwise would have been required to have been paid
to such Defaulting Lender).

 

(b) Defaulting
Lender Cure. If Borrower and Agent agree in writing that a Lender is no longer a Defaulting Lender, Agent will so notify the parties
hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein, such Lender will,
to the extent applicable, purchase at par that portion of outstanding Term Loan Advances of the other Lenders or take such other actions
as Agent may determine to be necessary to cause the Term Loan Advances to be held on a pro rata basis by the Lenders in accordance
with their respective Term Loan Commitment Percentages, whereupon such Lender will cease to be a Defaulting Lender; provided that
no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of Borrower while such Lender
was a Defaulting Lender; and provided further that, except to the extent otherwise expressly agreed by the affected parties, no
change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from
such Lender having been a Defaulting Lender.

 

(c) Termination
of Defaulting Lender. Borrower may terminate the unused amount of the Term Loan Commitment of any Lender that is a Defaulting Lender
upon not less than ten (10) Business Days’ prior notice to Agent (which shall promptly notify the Lenders thereof), and in such
event the provisions of Section 9.10(a)(ii) will apply to all amounts thereafter paid by Borrower for the account of such Defaulting
Lender under this Agreement (whether on account of principal, interest, fees, indemnity or other amounts); provided that (i) no
Event of Default shall have occurred and be continuing, and (ii) such termination shall not be deemed to be a waiver or release of any
claim Borrower, Agent or any Lender may have against such Defaulting Lender.

 

(d) If
the Person serving as Agent is a Defaulting Lender pursuant to clause (d) of the definition thereof, the non-Defaulting Lenders may,
to the extent permitted by applicable law, by notice in writing to Borrower and such Person, remove such Person as Agent and, in consultation
with Borrower, appoint a successor. If no such successor shall have been so appointed by the non-Defaulting Lenders and shall have accepted
such appointment within thirty (30) days (or such earlier day as shall be agreed by the non-Defaulting Lenders) (the “Removal
Effective Date”), then such removal shall nonetheless become effective in accordance with such notice on the Removal Effective
Date.

 

 9.10.2 Erroneous Payments.

 

(a) If
the Agent notifies a Lender or any Person who has received funds on behalf of a Lender (any such Lender or other recipient, a “Payment
Recipient”) that the Agent has determined in its sole discretion (whether or not after receipt of any notice under immediately
succeeding clause (b)) that any funds received by such Payment Recipient from the Agent or any of its Affiliates were erroneously transmitted
to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Lender or other Payment
Recipient on its behalf) (any such funds, whether received as a payment, prepayment or repayment of principal, interest, fees, distribution
or otherwise, individually and collectively, an “Erroneous Payment”) and demands the return of such Erroneous Payment
(or a portion thereof), such Erroneous Payment shall at all times remain the property of the Agent and shall be segregated by the Payment
Recipient and held in trust for the benefit of the Agent, and such Lender (or, with respect to any Payment Recipient who received such
funds on its behalf, shall cause such Payment Recipient to) promptly, but in no event later than two Business Days thereafter, return
to the Agent the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in
the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or
portion thereof) was received by such Payment Recipient to the date such amount is repaid to the Agent in same day funds at the greater
of the Federal Funds Effective Rate and a rate determined by the Agent in accordance with banking industry rules on interbank compensation
from time to time in effect. A notice of the Agent to any Payment Recipient under this clause (a) shall be conclusive, absent manifest
error.

 

    25

     

    

 

 

(b)
Without limiting immediately preceding clause (a), each Lender or any Person who has received funds on behalf of a Lender, hereby further
agrees that if it receives a payment, prepayment or repayment (whether received as a payment, prepayment or repayment of principal, interest,
fees, distribution or otherwise) from the Agent (or any of its Affiliates) (x) that is in a different amount than, or on a different
date from, that specified in a notice of payment, prepayment or repayment sent by the Agent (or any of its Affiliates) with respect to
such payment, prepayment or repayment, (y) that was not preceded or accompanied by a notice of payment, prepayment or repayment sent
by the Agent (or any of its Affiliates), or (z) that such Lender or other such recipient, otherwise becomes aware was transmitted, or
received, in error or by mistake (in whole or in part) in each case:

 

(i)
(A) in the case of immediately preceding clauses (x) or (y), an error shall be presumed to have been made (absent written confirmation
from the Agent to the contrary) or (B) an error has been made (in the case of immediately preceding clause (z)), in each case, with respect
to such payment, prepayment or repayment; and

 

(ii)
such Lender shall (and shall cause any other recipient that receives funds on its respective behalf to) promptly (and, in all events,
within one Business Day of its knowledge of such error) notify the Agent of its receipt of such payment, prepayment or repayment, the
details thereof (in reasonable detail) and that it is so notifying the Agent pursuant to this Section 9.10.2(b).

 

(c)
Each Lender hereby authorizes the Agent to set off, net and apply any and all amounts at any time owing to such Lender under any Loan
Document, or otherwise payable or distributable by the Agent to such Lender from any source, against any amount due to the Agent under
clause (a) hereof or under the indemnification provisions of this Agreement.

 

(d)
In the event that an Erroneous Payment (or portion thereof) is not recovered by the Agent for any reason, after demand therefor by the
Agent in accordance with clause (a) hereof, from any Lender that has received such Erroneous Payment (or portion thereof) (and/or from
any Payment Recipient who received such Erroneous Payment (or portion thereof) on its respective behalf) (such unrecovered amount, an
“Erroneous Payment Return Deficiency”), upon the Agent’s notice to such Lender at any time, (i) such Lender
shall be deemed to have assigned all Obligations owing from Borrower to such Lender hereunder (but not its Term Loan Commitments) with
respect to which such Erroneous Payment was made in an amount equal to the Erroneous Payment Return Deficiency (or such lesser amount
as the Agent may specify) (such assignment of the Loans (but not Commitments), the “Erroneous Payment Deficiency Assignment”)
at par plus any accrued and unpaid interest (with the assignment fee to be waived by the Agent in such instance), and is hereby (together
with the Borrower) deemed to execute and deliver an Assignment and Assumption with respect to such Erroneous Payment Deficiency Assignment,
and such Lender shall deliver any promissory notes (if any) evidencing such Obligations to the Borrower or the Agent, (ii) the Agent
as the assignee Lender shall be deemed to acquire the Erroneous Payment Deficiency Assignment, (iii) upon such deemed acquisition, the
Agent as the assignee Lender shall become a Lender, hereunder with respect to such Erroneous Payment Deficiency Assignment and the assigning
Lender shall cease to be a Lender hereunder with respect to such Erroneous Payment Deficiency Assignment, excluding, for the avoidance
of doubt, its obligations under the indemnification provisions of this Agreement and its applicable Term Loan Commitments which shall
survive as to such assigning Lender, and (iv) the Agent may reflect in the register (if any) its ownership interest in the Obligations
subject to the Erroneous Payment Deficiency Assignment. The Agent may, in its discretion, sell any Obligations acquired pursuant to an
Erroneous Payment Deficiency Assignment and upon receipt of the proceeds of such sale, the Erroneous Payment Return Deficiency owing
by the applicable Lender shall be reduced by the net proceeds of the sale of such portion of the Obligations, and the Agent shall retain
all other rights, remedies and claims against such Lender (and/or against any recipient that receives funds on its respective behalf).
For the avoidance of doubt, no Erroneous Payment Deficiency Assignment will reduce the Term Loan Commitments of any Lender and such Term
Loan Commitments shall remain available in accordance with the terms of this Agreement. In addition, each party hereto agrees that, except
to the extent that the Agent has sold any portion of the Obligations acquired pursuant to an Erroneous Payment Deficiency Assignment,
and irrespective of whether the Agent may be equitably subrogated, the Agent shall be contractually subrogated to all the rights and
interests of the applicable Lender under the Loan Documents with respect to each Erroneous Payment Return Deficiency (the “Erroneous
Payment Subrogation Rights”).

 

    26

     

    

 

(e)
The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed
by the Borrower or any Guarantor, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount
of such Erroneous Payment that is, comprised of funds received by the Agent from the Borrower or any Guarantor for the purpose of making
such Erroneous Payment.

 

(f)
To the extent permitted by applicable law, no Payment Recipient shall assert any right or claim to an Erroneous Payment, and hereby waives,
and is deemed to waive, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim
by the Agent for the return of any Erroneous Payment received, including without limitation any defense based on “discharge for
value” or any similar doctrine

 

(a)
Each party’s obligations, agreements and waivers under this Section 9.10.2 shall survive the resignation or replacement of the
Agent, any transfer of rights or obligations by, or the replacement of, a Lender, the termination of the Term Loan Commitments and/or
the repayment, satisfaction or discharge of all Obligations (or any portion thereof) under any Loan Document.

 

 10   NOTICES

 

All
notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must
be in writing and shall be deemed to have been validly served, given, or delivered:

 

(a)
upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or certified mail
return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail; (c) one (1) Business Day
after deposit with a reputable overnight courier with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all
of which shall be addressed to the party to be notified and sent to the address or email address indicated below; provided that, for
clause (b), if such notice, consent, request, approval, demand or other communication is not sent during the normal business hours of
the recipient, it shall be deemed to have been sent at the opening of business on the next Business Day of the recipient. Agent or Borrower
may change its mailing or electronic mail address by giving the other party written notice thereof in accordance with the terms of this
Section 10.

  

	 	If to Borrower:  	 	INMUNE BIO INC.
	 	 	 	1200 Prospect Street, Suite 525
	 	 	 	La Jolla CA 92037
	 	 	 	Attn: David Moss
	 	 	 	Email: dmoss@inmunebio.com
	 	 	 	 
	 	 	 	Provided that the foregoing address shall be considered updated as of the Moving Date to Borrower’s new headquarters location for which Borrower shall provide Lenders notice of such move.
	 	 	 	 
	 	with a copy to (which shall 	 	 
	 	not constitute notice):  	 	Sichenzia Ross Ference LLP
	 	 	 	1185 Avenue of the Americas, 31st Floor
	 	 	 	New York, New York 10036
	 	 	 	Attn: Marc Ross
	 	 	 	Email: mross@srf.law
	 	 	 	 
	 	If to Agent or SVB:  	 	Silicon Valley Bank
	 	 	 	4370 La Jolla Village Drive
	 	 	 	Suite 1050
	 	 	 	San Diego, CA 92122
	 	 	 	Attn: Kristine Rohmer
	 	 	 	Email: KRohmer@svb.com
	 	 	 	 
	 	with a copy to (which  	 	 
	 	shall not constitute  	 	 
	 	notice):  	 	DLA Piper LLP (US)
	 	 	 	401 B Street, Suite 1700
	 	 	 	San Diego, CA 92101
	 	 	 	Attn: Matt Schwartz
	 	 	 	Email: Matt.Schwartz@us.dlapiper.com
	 	 	 	 
	 	If to SVB Capital:  	 	SVB Innovation Credit Fund VIII, L.P.
	 	 	 	c/o SVB Capital
	 	 	 	2770 Sand Hill Road
	 	 	 	Menlo Park, CA 94025
	 	 	 	Attn: SVB Capital Finance and Operations
	 	 	 	Email: svbcapitalcredit@svbank.com;
	 	 	 	SVBCapCreditFinance@svb.com

    27

     

    

 

11   CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER; JUDICIAL REFERENCE.

 

Except
as otherwise expressly provided in any of the Loan Documents, California law governs the Loan Documents without regard to principles
of conflicts of law that would require the application of the laws of another jurisdiction. Borrower, Agent, and Lenders each irrevocably
and unconditionally submit to the exclusive jurisdiction of the State and Federal courts in Santa Clara County, California; provided,
however, that nothing in this Agreement shall be deemed to operate to preclude Agent or Lenders from bringing suit or taking other legal
action in any other jurisdiction with respect to the Loan Documents or to realize on the Collateral or any other security for the Obligations,
or to enforce a judgment or other court order in favor of Agent or any Lender. Borrower expressly, irrevocably and unconditionally submits
and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby irrevocably and unconditionally
waives, to the fullest extent permitted by Applicable Law, any objection that it may have based upon lack of personal jurisdiction, improper
venue, or forum non conveniens and hereby irrevocably and unconditionally consents to the granting of such legal or equitable relief
as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints, and other process issued
in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified
mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in accordance with, Section 10 of this Agreement
and that service so made shall be deemed completed upon the earlier to occur of Borrower’s actual receipt thereof or three (3)
days after deposit in the U.S. mails, proper postage prepaid.

 

TO
THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BORROWER, AGENT AND EACH LENDER EACH WAIVES THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM
OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT,
TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT.
EACH PARTY HERETO HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.

 

WITHOUT
INTENDING IN ANY WAY TO LIMIT THE PARTIES’ AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of
the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between
them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree,
by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance with California Code of Civil Procedure
Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal
courts), sitting without a jury, in Santa Clara County, California; and the parties hereby submit to the jurisdiction of such court.
The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure
Sections 638 through 645.1, inclusive. The private judge shall have the power, among others, to grant provisional relief, including without
limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing receivers. All such proceedings
shall be closed to the public and confidential and all records relating thereto shall be permanently sealed. If during the course of
any dispute, a party desires to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference
procedures, then such party may apply to the Santa Clara County, California Superior Court for such relief. The proceeding before the
private judge shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial
proceedings. The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under
the rules of discovery applicable to judicial proceedings. The private judge shall oversee discovery and may enforce all discovery rules
and orders applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or appointed
private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement
of decision thereon pursuant to California Code of Civil Procedure Section 644(a). Nothing in this paragraph shall limit the right of
any party at any time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies. The private judge
shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.

 

This
Section 11 shall survive the termination of this Agreement and the repayment of all Obligations.

 

12
  GENERAL PROVISIONS

 

12.1
Termination Prior to Term Loan Maturity Date; Survival. All covenants, representations and warranties made in this Agreement continue
in full force until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations)
have been satisfied. So long as Borrower has satisfied the Obligations (other than inchoate indemnity obligations, any other obligations
which, by their terms, are to survive the termination of this Agreement and the repayment of all Obligations, and any Obligations under
Bank Services Agreements that are cash collateralized in accordance with Section 3.1 of this Agreement), this Agreement may be terminated
prior to the Term Loan Maturity Date by Borrower, effective three (3) Business Days after written notice of termination is given to Agent.
Those obligations that are expressly specified in this Agreement as surviving this Agreement’s termination and the repayment of
all Obligations shall continue to survive notwithstanding this Agreement’s termination and the repayment of all Obligations.

 

12.2
Successors and Assigns. This Agreement binds and is for the benefit of the successors and permitted assigns of each party. Borrower
may not assign or transfer this Agreement or any rights or obligations under it without Agent and Lenders’ prior written consent
(which may be granted or withheld in Agent’s and Lenders’ sole discretion) and any other attempted assignment or transfer
by Borrower shall be null and void. Agent and each Lender has the right, without the consent of or notice to Borrower, to sell, transfer,
assign, negotiate, or grant participation in all or any part of, or any interest in, such Lender’s obligations, rights, and benefits
under this Agreement and the other Loan Documents (other than the Warrant, as to which assignment, transfer and other such actions are
governed by the terms thereof).

 

    28

     

    

 
12.3
Indemnification.

 

(a)
General Indemnification. Borrower shall indemnify, defend and hold Agent, each Lender and their respective partners, directors,
officers, employees, agents, trustees, administrators, managers, advisors and representatives of Agent and its Affiliates or any Lender
and its Affiliates (each, an “Indemnified Person”) harmless against: (i) all losses, claims, damages, liabilities
and related expenses (including Lenders’ Expenses and the reasonable fees, charges and disbursements of any counsel for any Indemnified
Person) (collectively, “Claims”) arising out of, in connection with, or as a result of (i) the execution or delivery
of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties
hereto of their respective obligations hereunder or thereunder or the consummation of the transactions contemplated hereby or thereby,
(ii) any Credit Extension or the use or proposed use of the proceeds therefrom, (iii) any actual or alleged presence or release of hazardous
materials on or from any property owned or operated by Borrower or any of its Subsidiaries, or any environmental liability related in
any way to Borrower or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating
to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by Borrower, and regardless
of whether any Indemnified Person is a party thereto; provided that such indemnity shall not, as to any Indemnified Person, be available
to the extent that such losses, claims, damages, liabilities or related expenses are determined by a court of competent jurisdiction
by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnified Person. All
amounts due under this Section 12.3 shall be payable promptly after demand therefor.

 

(b)
Waiver of Consequential Damages, Etc. To the fullest extent permitted by Applicable Law, Borrower shall not assert, and hereby
waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages
(as opposed to direct or actual damages) or any loss of profits arising out of, in connection with, or as a result of, this Agreement,
any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Credit
Extension, or the use of the proceeds thereof. No Indemnified Person shall be liable for any damages arising from the use by unintended
recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission
systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby.

 

This
Section 12.3 shall survive the termination of this Agreement and the repayment of all Obligations until all statutes of limitation with
respect to the Claims, losses, and expenses for which indemnity is given shall have run.

 

12.4
Time of Essence. Time is of the essence for the performance of all Obligations in this Agreement.

 

12.5
Severability of Provisions. Each provision of this Agreement is severable from every other provision in determining the enforceability
of any provision.

 

12.6
Amendments in Writing; Waiver; Integration. No purported amendment or modification of any Loan Document, or waiver, discharge or
termination of any obligation under any Loan Document, shall be effective unless, and only to the extent, expressly set forth in a writing
signed by Agent, with the consent of the Lenders in accordance with the Lender Intercreditor Agreement or, if such item is not addressed
in the Lender Intercreditor Agreement, as consented to by a majority of the Lenders, and Borrower. Without limiting the generality of
the foregoing, no oral promise or statement, nor any action, inaction, delay, failure to require performance or course of conduct shall
operate as, or evidence, an amendment, supplement or waiver or have any other effect on any Loan Document. Any waiver granted shall be
limited to the specific circumstance expressly described in it, and shall not apply to any subsequent or other circumstance, whether
similar or dissimilar, or give rise to, or evidence, any obligation or commitment to grant any further waiver. The Loan Documents represent
the entire agreement about this subject matter and supersede prior negotiations or agreements. All prior agreements, understandings,
representations, warranties, and negotiations between the parties about the subject matter of the Loan Documents merge into the Loan
Documents.

 

12.7
Counterparts. This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each
of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. Delivery of an executed signature
page of this Agreement by electronic mail transmission shall be effective as delivery of a manually executed counterpart hereof.

 

12.8
Confidentiality. Agent and each Lender agrees to maintain the confidentiality of Information (as defined below), except that Information
may be disclosed (a) to Agent and/or any Lender’s Subsidiaries and Affiliates, and their respective employees, directors, agents,
attorneys, investors, potential investors accountants and other professional advisors (collectively, “Representatives”
and, together with Agent and the Lenders, collectively, “Lender Entities”); (b) to prospective transferees, assignees,
credit providers or purchasers of Agent’s or Lenders’ interests under or in connection with this Agreement and their Representatives
(provided, however, Agent and the Lenders shall use commercially reasonable efforts to obtain any such prospective transferee’s,
assignee’s, credit provider’s, purchaser’s or their Representatives’ agreement to the terms of this provision);
(c) as required by law, regulation, subpoena, or other order; (d) to Agent’s or any Lender’s regulators or as otherwise required
or requested in connection with Agent’s or any Lender’s examination or audit; (e) in connection with the exercise of remedies
under the Loan Documents or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights
hereunder or thereunder; and (f) to third-party service providers of Agent and/or any Lender so long as such service providers have executed
a confidentiality agreement with Agent or the Lenders, as applicable, with terms no less restrictive than those contained herein. “Information”
means all information received from Borrower regarding Borrower or its business, in each case other than information that is either:
(i) in the public domain or in Agent’s or any Lender’s possession when disclosed to Agent or such Lender, or becomes part
of the public domain (other than as a result of its disclosure by Agent or a Lender in violation of this Agreement) after disclosure
to Agent and/or the Lenders; or (ii) disclosed to Agent and/or a Lender by a third party, if Agent or such Lender, as applicable, does
not know that the third party is prohibited from disclosing the information.

 

    29

     

    

 

12.9
Electronic Execution of Documents. The words “execution,” “signed,” “signature” and words of
like import in any Loan Document shall be deemed to include electronic signatures, including any Electronic Signature as defined in the
Electronic Transactions Law (2003 Revision) of the Cayman Islands (the “Cayman Islands Electronic Signature Law”),
if applicable, or the keeping of records in electronic form, including any Electronic Record, as defined in Cayman Islands Electronic
Signature Law, each of which shall be of the same legal effect, validity and enforceability as a manually executed signature or the use
of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any Applicable Law, including, without
limitation, any state law based on the Uniform Electronic Transactions Act or the Cayman Islands Electronic Signature Law; provided,
however that sections 8 and 19(3) of the Cayman Islands Electronic Signature Law shall not apply to this Agreement or the execution or
delivery thereof.

 

12.10
Right of Setoff. Borrower hereby grants to Agent, for the ratable benefit of the Lenders, a Lien, security interest, and a right
of setoff as security for all Obligations to Agent and the Lenders, whether now existing or hereafter arising upon and against all deposits,
credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of Agent or any entity under the
control of Agent (including a subsidiary of Agent) or in transit to any of them, and other obligations owing to Agent or any such entity.
At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, Agent or any Lender may
setoff the same or any part thereof and apply the same to any Obligation of Borrower then due regardless of the adequacy of any other
collateral securing the Obligations. ANY AND ALL RIGHTS TO REQUIRE AGENT OR ANY LENDER TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT
TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS
OR OTHER PROPERTY OF BORROWER, ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED.

 

12.11
Captions and Section References. The headings used in this Agreement are for convenience only and shall not affect the interpretation
of this Agreement. Unless indicated otherwise, section references herein are to sections of this Agreement.

 

12.12
Construction of Agreement. The parties hereto mutually acknowledge that they and their attorneys have participated in the preparation
and negotiation of this Agreement. In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused
the uncertainty to exist.

 

12.13
Relationship. The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement. The parties
do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different
from those of parties to an arm’s-length contract.

 

12.14
Third Parties. Nothing in this Agreement, whether express or implied, is intended to: (a) confer any benefits, rights or remedies
under or by reason of this Agreement on any Persons other than the express parties to it and their respective permitted successors and
assigns; (b) relieve or discharge the obligation or liability of any Person not an express party to this Agreement; or (c) give any Person
not an express party to this Agreement any right of subrogation or action against any party to this Agreement.

 

12.15
Anti-Terrorism Law. Each Lender hereby notifies Borrower that, pursuant to the requirements of Anti-Terrorism Law, it may be required
to obtain, verify and record information that identifies Borrower, which information may include the name and address of Borrower and
other information that will allow Lender to identify Borrower in accordance with Anti-Terrorism Law. Borrower hereby agrees to take any
action necessary to enable each Lender to comply with the requirements of Anti-Terrorism Law.

 

    30

     

    

 

13   ACCOUNTING TERMS AND OTHER DEFINITIONS

 

13.1 Accounting and Other Terms.

 

(a)
Accounting terms not defined in this Agreement shall be construed following GAAP. Calculations and determinations must be made following
GAAP (except for with respect to unaudited financial statements for the absence of footnotes and subject to year-end audit adjustments),
provided that if at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan
Document, and either Borrower, Agent, and/or any Lender shall so request, Borrower and Agent shall negotiate in good faith to amend such
ratio or requirement to preserve the original intent thereof in light of such change in GAAP; provided, further, that, until so amended,
(i) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (ii) Borrower shall
provide Agent financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth
a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.

 

(b)
As used in the Loan Documents: (i) the words “shall” or “will” are mandatory, the word “may” is permissive,
the word “or” is not exclusive, the words “includes” and “including” are not limiting, the singular
includes the plural, and numbers denoting amounts that are set off in brackets are negative; (ii) the term “continuing” in
the context of an Event of Default means that the Event of Default has not been remedied (if capable of being remedied) or waived; and
(iii) whenever a representation or warranty is made to Borrower’s knowledge or awareness, to the “best of” Borrower’s
knowledge, or with a similar qualification, knowledge or awareness means the actual knowledge, after reasonable investigation, of any
Responsible Officer.

 

13.2
Definitions. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in this Section 13.2 of
this Agreement. All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code
to the extent such terms are defined therein. As used in this Agreement, the following capitalized terms have the following meanings:

 

“Account”
is, as to any Person, any “account” of such Person as “account” is defined in the Code with such additions to
such term as may hereafter be made, and includes, without limitation, all accounts receivable and other sums owing to such Person.

 

“Account
Debtor” is any “account debtor” as defined in the Code with such additions to such term as may hereafter be made.

 

“Affiliate”
is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any Person that controls or
is controlled by or is under common control with the Person, and each of that Person’s senior executive officers, directors, partners
and, for any Person that is a limited liability company, that Person’s managers and members.

 

“Agent”
is defined in the preamble hereof.

 

“Agreement”
is defined in the preamble hereof.

 

“Anti-Terrorism
Law” means any law relating to terrorism or money-laundering, including Executive Order No. 13224 and the USA Patriot Act.

 

“Applicable
Law” means all applicable provisions of constitutions, laws, statutes, ordinances, rules, treaties, regulations, permits, licenses,
approvals, interpretations and orders of courts or Governmental Authorities and all orders and decrees of all courts and arbitrators.

 

    31

     

    

 

“Authorized
Signer” means any individual listed in Borrower’s Borrowing Resolution who is authorized to execute the Loan Documents,
including making (and executing if applicable) any Credit Extension request, on behalf of Borrower.

 

“Bank
Services” are any products, credit services, and/or financial accommodations previously, now, or hereafter provided to Borrower
or any of its Subsidiaries by SVB or any SVB Affiliate, including, without limitation, any letters of credit, cash management services
(including, without limitation, merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest
rate swap arrangements, and foreign exchange services as any such products or services may be identified in SVB’s various agreements
related thereto (each, a “Bank Services Agreement”).

 

“Bank
Services Agreement” is defined in the definition of Bank Services.

 

“Board”
means Borrower’s board of directors or equivalent governing body.

 

“Borrower”
is set forth on Schedule I hereto.

 

“Borrower’s
Books” are all Borrower’s books and records including ledgers, federal and state tax returns, records regarding Borrower’s
assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment
containing such information.

 

“Borrowing
Resolutions” are, with respect to any Person, those resolutions adopted by such Person’s board of directors (and, if
required under the terms of such Person’s Operating Documents, stockholders) and delivered by such Person to Agent approving the
Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a certificate executed by its
secretary on behalf of such Person certifying (a) such Person has the authority to execute, deliver, and perform its obligations under
each of the Loan Documents to which it is a party, (b) that set forth as a part of or attached as an exhibit to such certificate is a
true, correct, and complete copy of the resolutions then in full force and effect authorizing and ratifying the execution, delivery,
and performance by such Person of the Loan Documents to which it is a party, (c) the name(s) of the Person(s) authorized to execute the
Loan Documents, including making (and executing if applicable) any Credit Extension request, on behalf of such Person, together with
a sample of the true signature(s) of such Person(s), and (d) that Agent and Lenders may conclusively rely on such certificate unless
and until such Person shall have delivered to Agent and Lenders a further certificate canceling or amending such prior certificate.

 

“Business
Day” is a day other than a Saturday, Sunday or other day on which commercial banks in the State of California are authorized
or required by law to close, except that if any determination of a “Business Day” shall relate to an FX Contract, the term
“Business Day” shall be a FX Business Day.

 

“Cash
Equivalents” are (a) marketable direct obligations issued or unconditionally guaranteed by the United States or any agency
or any State thereof having maturities of not more than one (1) year from the date of acquisition;

 

(b)
commercial paper maturing no more than one (1) year after its creation and having the highest rating from either Standard & Poor’s
Ratings Group or Moody’s Investors Service, Inc.; (c) SVB’s certificates of deposit issued maturing no more than one (1)
year after issue; and (d) money market funds at least ninety-five percent (95.0%) of the assets of which constitute Cash Equivalents
of the kinds described in clauses (a) through (c) of this definition.

 

“Change
in Control” means (a) at any time, any “person” or “group” (as such terms are used in Sections 13(d)
and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the “beneficial
owner” (as defined in Rules 13(d)-3 and 13(d)-5 under the Exchange Act), directly or indirectly, of twenty-five Percent (25.0%)
or more of the ordinary voting power for the election of directors, partners, managers and members, as applicable, of Borrower (determined
on a fully diluted basis) other than by the sale of Borrower’s equity securities in a public offering or to venture capital or
private equity investors so long as Borrower identifies to the Agent and the Lenders the venture capital or private equity investors
at least seven (7) Business Days prior to the closing of the transaction and provides to Agent and the Lenders a description of the material
terms of the transaction; (b) during any period of 12 consecutive months, a majority of the members of the Board of Borrower cease to
be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose
election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting
at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or
nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting
at the time of such election or nomination at least a majority of that board or equivalent governing body; or (c) at any time, Borrower
shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100.0%) of each class of outstanding
stock, partnership, membership, or other ownership interest or other equity securities of each Subsidiary of Borrower free and clear
of all Liens (except Permitted Liens).

 

    32

     

    

 

“Change
in Law” means the occurrence, after the Effective Date, of: (a) the adoption or taking effect of any law, rule, regulation
or treaty; (b) any change in Applicable Law or in the administration, interpretation, implementation or application thereof by any Governmental
Authority; or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any
Governmental Authority; provided that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer
Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests,
rules, guidelines or directives promulgated by Agent for International Settlements, the Basel Committee on Banking Supervision (or any
successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in
each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted or issued.

 

“Claims”
is defined in Section 12.3.

 

“Code”
is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of California; provided, that,
to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different
Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern; provided further, that
in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with
respect to, Agent’s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the
State of California, the term “Code” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction
solely for purposes of the provisions thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions
relating to such provisions.

 

“Collateral”
consists of all of Borrower’s right, title and interest in and to the following personal property:

 

(a)
All goods, Accounts (including health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases,
license agreements, franchise agreements, General Intangibles (except as provided below), commercial tort claims, documents, instruments
(including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts, certificates of deposit, fixtures,
letters of credit rights (whether or not the letter of credit is evidenced by a writing), securities, securities accounts, securities
entitlements and all other investment property, supporting obligations, and financial assets, whether now owned or hereafter acquired,
wherever located; and

 

(b)
All Borrower’s Books relating to the foregoing, and any and all claims, rights and interests in any of the above and all substitutions
for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds
of any or all of the foregoing.

 

(c)
Notwithstanding the foregoing, the Collateral does not include any Intellectual Property; provided, however, the Collateral shall include
all Accounts and all proceeds of Intellectual Property. If a judicial authority (including a U.S. Bankruptcy Court) would hold that a
security interest in the underlying Intellectual Property is necessary to have a security interest in such Accounts and such property
that are proceeds of Intellectual Property, then the Collateral shall automatically, and effective as of the Effective Date, include
the Intellectual Property to the extent necessary to permit perfection of Agent’s, for the ratable benefit of the Lenders, security
interest in such Accounts and such other property of Borrower that are proceeds of the Intellectual Property.

 

(d)
Pursuant to the terms of a certain negative pledge arrangement with Agent and the Lenders, Borrower has agreed not to encumber any of
its Intellectual Property without Agent and the Lenders’ prior written consent.

 

    33

     

    

 

“Collateral
Account” is any Deposit Account, Securities Account, or Commodity Account.

 

“Commitment”
and “Commitments” means the Term Loan Commitment(s).

 

“Commodity
Account” is any “commodity account” as defined in the Code with such additions to such term as may hereafter be
made.

 

“Compliance
Statement” is that certain statement in the form attached hereto as Exhibit A.

 

“Connection
Income Taxes” means Other Connection Taxes that are imposed on or measured by net income (however denominated) or that are
franchise Taxes or branch profits Taxes.

 

“Contingent
Obligation” is, for any Person, any direct or indirect liability of that Person for (a) any direct or indirect guaranty by
such Person of any indebtedness, lease, dividend, letter of credit, credit card or other obligation of another, (b) any other obligation
endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (c) any
obligations for undrawn letters of credit for the account of that Person; and (d) all obligations from any interest rate, currency or
commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against
fluctuation in interest rates, currency exchange rates or commodity prices; but “Contingent Obligation” does not include
endorsements in the ordinary course of business. The amount of a Contingent Obligation is the stated or determined amount of the primary
obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined
by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.

 

“Control
Agreement” is any control agreement entered into among the depository institution at which Borrower maintains a Deposit Account
or the securities intermediary or commodity intermediary at which Borrower maintains a Securities Account or a Commodity Account, Borrower,
and Agent pursuant to which Agent obtains control (within the meaning of the Code) for the benefit of the Lenders over such Deposit Account,
Securities Account, or Commodity Account.

 

“Copyrights”
are any and all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and
derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret.

 

“Credit
Extension” is any Term Loan Advance, or any other extension of credit by any Lender for Borrower’s benefit.

 

“Default”
means any event which with notice or passage of time or both, would constitute an Event of Default.

 

“Default
Rate” is defined in Section 1.2(c).

 

“Defaulting
Lender” is, subject to Section 9.10(b), any Lender that (a) has failed to (i) fund all or any portion of its Term Loan
Advances within two (2) Business Days of the date such Term Loan Advances were required to be funded hereunder unless such Lender
notifies Agent and Borrower in writing that such failure is the result of such Lender’s reasonable determination that one or
more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be
specifically identified in such writing) has not been satisfied, or (ii) pay to Agent or any other Lender any other amount required
to be paid by it hereunder within two (2) Business Days of the date when due, (b) has notified Borrower or Agent in writing that it
does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless such writing
or public statement relates to such Lender’s obligation to fund a Term Loan Advance hereunder and states that such position is
based on such Lender’s reasonable determination that a condition precedent to funding (which condition precedent, together
with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has
failed, within three (3) Business Days after written request by Agent or Borrower, to confirm in writing to Agent and Borrower that
it will comply with its prospective funding obligations hereunder (provided that such Lender shall cease to be a Defaulting Lender
pursuant to this clause (c) upon receipt of such written confirmation by Agent and Borrower), or (d) has, or has a direct or
indirect parent company that has, (i) become the subject of an Insolvency Proceeding, or (ii) had appointed for it a receiver,
custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization
or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal
regulatory authority acting in such a capacity; provided that a Lender shall not be a Defaulting Lender solely by virtue of the
ownership or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental
Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts
within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such
Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender. Any
determination by Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (d) above shall be
conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender (subject to Section
10.10(b)) upon delivery of written notice of such determination to Borrower and each Lender.

 

    34

     

    

 

“Deposit
Account” is any “deposit account” as defined in the Code with such additions to such term as may hereafter
be made.

 

“Designated
Deposit Account” is the deposit account established by Borrower with SVB for purposes of receiving Credit Extensions.

 

“Disbursement
Letter” is that certain form attached hereto as Exhibit C.

 

“Division”
means, in reference to any Person which is an entity, the division of such Person into two (2) or more separate Persons, with the dividing
Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under
Section 18-217 of the Delaware Limited Liability Company Act for limited liability companies formed under Delaware law, Section 17-220
of the Delaware Revised Uniform Limited Partnership Act for limited partnerships formed under Delaware law, or any analogous action taken
pursuant to any other Applicable Law with respect to any corporation, limited liability company, partnership or other entity.

 

“Dollars,”
“dollars” or use of the sign “$” means only lawful money of the United States and not any other currency,
regardless of whether that currency uses the “$” sign to denote its currency or may be readily converted into lawful money
of the United States.

 

“Dollar
Equivalent” is, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any
amount denominated in a Foreign Currency, the equivalent amount therefor in Dollars as determined by Agent at such time on the basis
of the then-prevailing rate of exchange in San Francisco, California, for sales of the Foreign Currency for transfer to the country issuing
such Foreign Currency.

 

“Effective
Date” is set forth on Schedule I hereto.

 

“Environmental
Laws” means any Applicable Law (including any permits, concessions, grants, franchises, licenses, agreements or governmental
restrictions) relating to pollution or the protection of health, safety or the environment or the release of any materials into the environment
(including those related to hazardous materials, air emissions, discharges to waste or public systems and health and safety matters).

 

“Equipment”
is all “equipment” as defined in the Code with such additions to such term as may hereafter be made, and includes without
limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing.

 

“Equity
Event” means Borrower’s delivery to Agent of evidence, in form and substance satisfactory to Agent in its good faith
business judgment, confirming that Borrower has raised, after the Effective Date but on or prior to June 30, 2022, net cash proceeds,
from the sale or issuance of Borrower’s equity securities, in an aggregate amount not less than Fifty Million Dollars ($50,000,000)
on terms and conditions acceptable to Agent in its good faith business judgment.

 

“ERISA”
is the Employee Retirement Income Security Act of 1974, as amended, and its regulations.

 

“Erroneous
Payment” has the meaning assigned to it in Section 9.11(a).

 

“Erroneous
Payment Deficiency Assignment” has the meaning assigned to it in Section 9.11(d).

 

“Erroneous
Payment Return Deficiency” has the meaning assigned to it in Section 9.11(d).

 

“Erroneous
Payment Subrogation Rights” has the meaning assigned to it in Section 9.11(d).

 

“Event
of Default” is defined in Section 7.

 

“Exchange
Act” is the Securities Exchange Act of 1934, as amended.

 

    35

     

    

 

“Excluded
Taxes” means any of the following Taxes imposed on or with respect to SVB or required to be withheld or deducted from a
payment to SVB, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in
each case, (i) imposed as a result of SVB being organized under the laws of, or having its principal office or its applicable
lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other
Connection Taxes, (b) U.S. federal withholding Taxes imposed on amounts payable to or for the account of SVB with respect to an
applicable interest in a Credit Extension pursuant to a law in effect on the date on which (i) SVB acquires such interest in the
Credit Extensions or (ii) SVB changes its lending office, except in each case to the extent that, pursuant to Section 1.8, amounts
with respect to such Taxes were payable either to SVB’s assignor immediately before SVB became a party hereto or to SVB
immediately before it changed its lending office, (c) Taxes attributable to SVB’s failure to comply with Section 1.8(e), and
(d) any withholding Taxes imposed under FATCA.

 

“FATCA”
means Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version
that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations
thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code and any fiscal or regulatory legislation,
rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing
such Sections of the Internal Revenue Code.

 

“Federal
Funds Effective Rate” means, for any day, the weighted average of the rates on overnight federal funds transactions with members
of the Federal Reserve System arranged by federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve
Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day
of such transactions received by SVB from three federal funds brokers of recognized standing selected by it.

 

“Final
Payment” is a payment (in addition to and not in substitution for the regular monthly payments of principal plus accrued interest)
equal to the original principal amount of each Term Loan Advance extended by the Lenders to Borrower hereunder multiplied by six and
one-half percent (6.5%), due on the earliest to occur of (a) the Term Loan Maturity Date, (b) the repayment of such Term Loan Advance
in full, (c) as required pursuant to Sections 1.1(c) or 1.1(d), or (d) the termination of this Agreement.

 

“Financial
Statement Repository” is SWLSReporting@svb.com or such other means of collecting information approved and designated by Agent
after providing notice thereof to Borrower from time to time.

 

“Foreign
Currency” is the lawful money of a country other than the United States.

 

“Funding
Date” is any date on which a Credit Extension is made to or for the account of Borrower which shall be a Business Day.

 

“FX
Business Day” is any day when (a) SVB’s Foreign Exchange Department is conducting its normal business and (b) the Foreign
Currency being purchased or sold by Borrower is available to SVB from the entity from which SVB shall buy or sell such Foreign Currency.

 

“FX
Contract” is any foreign exchange contract by and between Borrower and SVB under which Borrower commits to purchase from or
sell to SVB a specific amount of Foreign Currency at a set price or on a specified date.

 

“GAAP”
is generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American
Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other
statements by such other Person as may be approved by a significant segment of the accounting profession, which are applicable to the
circumstances as of the date of determination.

 

“General
Intangibles” is all “general intangibles” as defined in the Code in effect on the date hereof with such additions
to such term as may hereafter be made, and includes without limitation, all Intellectual Property, claims, income and other tax refunds,
security and other deposits, payment intangibles, contract rights, options to purchase or sell real or personal property, rights in all
litigation presently or hereafter pending (whether in contract, tort or otherwise), insurance policies (including without limitation
key man, property damage, and business interruption insurance), payments of insurance and rights to payment of any kind.

 

“Good
Faith Deposit” is defined in Section 1.3(c).

 

“Governmental
Approval” is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration,
filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority, including, without limitation,
Healthcare Permits.

 

“Governmental
Authority” is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality,
regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative
functions of or pertaining to government, any securities exchange and any self-regulatory organization.

 

“Group
Member” means Borrower and its Subsidiaries.

 

“Guarantor”
is any Person providing a Guaranty in favor of Lenders.

 

“Guaranty”
is any guarantee of all or any part of the Obligations, as the same may from time to time be amended, restated, modified or otherwise
supplemented.

    36

     

    

 

“Healthcare
Laws” means all Applicable Laws relating to the operation or management of hospitalist practices, the provision of hospitalist
services, proper billing and collection practices relating to the payment for healthcare services, insurance law (including law related
to payment for “no-fault” claims) and workers compensation law as they relate to the provision of, and billing and payment
for, healthcare services, patient healthcare, patient healthcare information, patient abuse, the quality and adequacy of rehabilitative
care, rate setting, equipment, personnel, operating policies, fee splitting, including, without limitation, (a) all federal and state
fraud and abuse laws, including, without limitation, the federal Anti-Kickback Statute (42 U.S.C. §1320a-7b(b)), the Stark Law (42
U.S.C. §1395nn), the civil False Claims Act (31 U.S.C. §3729 et seq.), the administrative False Claims Law (42 U.S.C. §
1320a-7b(a)), the Anti-Inducement Law (42 U.S.C. § 1320a-7a(a)(5)), the exclusion laws (42 U.S.C. § 1320a-7); (b) the Health
Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health
Act of 2009; (c) the Medicare Regulations and the Medicaid Program (Title XIX of the Social Security Act); (d) quality, safety and accreditation
standards and requirements of all applicable state laws or regulatory bodies; (e) all laws, policies, procedures, requirements and regulations
pursuant to which Healthcare Permits are issued; (f) any laws, regulations or administrative guidance with respect to fee splitting by
healthcare professionals and the corporate practice of medicine in any jurisdiction in which any Borrower or any Guarantor operates;
and (g) any and all comparable state or local laws and other applicable health care laws, regulations, manual provisions, policies and
administrative guidance, each of (a) through (g) as may be amended from time to time and the regulations promulgated pursuant to each
such law.

 

“Healthcare
Permit” means, with respect to any Person, a permit issued or required under Healthcare Laws applicable to the business of
Borrower or any Guarantor, or necessary in the possession, ownership, warehousing, marketing, promoting, sale, labeling, furnishing,
distribution or delivery of goods or services under Healthcare Laws applicable to the business of Borrower or any Guarantor.

 

“HIPAA”
means, collectively, the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology
for Economic Clinical Health (HITECKH) Act and the implementing regulations thereto.

 

“Indebtedness”
is (a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for
surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations,
(d) Contingent Obligations and (e) other short-and long-term obligations under debt agreements, lines of credit and extensions of credit.

 

“Indemnified
Person” is defined in Section 12.3.

 

“Indemnified
Taxes” means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation
of Borrower under any Loan Document and (b) to the extent not otherwise described in clause (a), Other Taxes.

 

“Information”
is defined in Section 12.8.

 

“Insolvency
Proceeding” is any proceeding by or against any Person under the United States Bankruptcy Code, or any other bankruptcy or
insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings
seeking reorganization, arrangement, receivership or other relief.

 

“Intellectual
Property” means, with respect to any Person, all of such Person’s right, title, and interest in and to the following:

 

(a)
its Copyrights, Trademarks and Patents;

 

(b)
any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how and operating
manuals;

 

(c)
any and all source code;

 

(d)
any and all design rights which may be available to such Person;

 

(e)
any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation,
to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above; and

 

(f)
all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents.

 

“Internal
Revenue Code” means the U.S. Internal Revenue Code of 1986, and the rules and regulations promulgated thereunder, each as amended
or modified from time to time.

 

“Inventory”
is all “inventory” as defined in the Code in effect on the date hereof with such additions to such term as may hereafter
be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process
and finished products, including without limitation such inventory as is temporarily out of Borrower’s custody or possession or
in transit and including any returned goods and any documents of title representing any of the above.

    37

     

    

 

“Investment”
is any beneficial ownership interest in any Person (including stock, partnership, membership, or other ownership interest or other equity
securities), and any loan, advance or capital contribution to any Person.

 

“Key
Person” is each of (i) Borrower’s Chief Executive Officer, which is Raymond J. Tesi as of the Effective Date and (ii)
Borrower’s Chief Financial Officer, which is David Moss as of the Effective Date.

 

“Lender”
and “Lenders” is defined in the preamble.

 

“Lender
Entities” is defined in Section 12.8.

 

“Lender
Intercreditor Agreement” is, collectively, any and all intercreditor agreement, master arrangement agreement or similar agreement
by and between SVB Capital and SVB, as each may be amended from time to time in accordance with the provisions thereof.

 

“Lenders’
Expenses” are all of Agent’s and the Lenders’ audit fees and expenses, costs, and expenses (including reasonable
attorneys’ fees and expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including,
without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to Borrower.

 

“Letter
of Credit” is a standby or commercial letter of credit issued by SVB upon request of Borrower based upon an application, guarantee,
indemnity, or similar agreement.

 

“Lien”
is a claim, mortgage, deed of trust, levy, attachment charge, pledge, hypothecation, security interest or other encumbrance of any kind,
whether voluntarily incurred or arising by operation of law or otherwise against any property.

 

“Loan
Documents” are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related
to this Agreement, the Perfection Certificate, the Warrant, each Disbursement Letter, the Lender Intercreditor Agreement, any Control
Agreement, any Bank Services Agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower, landlord
waivers and consents, bailee waivers and consents, and any other present or future agreement by Borrower with or for the benefit of Agent
and the Lenders in connection with this Agreement or Bank Services, all as amended, restated, or otherwise modified in accordance with
the terms thereof.

 

“Material
Adverse Change” is (a) a material impairment in the perfection or priority of Agent’s, for the ratable benefit of the
Lenders, Lien in the Collateral or in the value of such Collateral; (b) a material adverse change in the business, operations, or condition
(financial or otherwise) of Borrower; or (c) a material impairment of the prospect of repayment of any portion of the Obligations.

 

“Moving
Date” means the date on which Borrower relocates its headquarters to a new location.

 

“Obligations”
are Borrower’s obligations to pay when due any debts, principal, interest, fees, Lenders’ Expenses, the Final Payment, the
Prepayment Premium, the Erroneous Payment Subrogation Rights, and other amounts Borrower owes Agent or any Lender now or later, whether
under this Agreement, the other Loan Documents (other than the Warrant), or otherwise, including, without limitation, all obligations
relating to Bank Services, if any, and including interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations
of Borrower assigned to Agent and/or the Lenders, and to perform Borrower’s duties under the Loan Documents (other than the Warrant).

 

“OFAC”
is the Office of Foreign Assets Control of the United States Department of the Treasury and any successor thereto.

 

“Operating
Documents” are, for any Person, such Person’s formation documents, as certified by the Secretary of State (or equivalent
agency) of such Person’s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the Effective
Date, and, (a) if such Person is a corporation, its bylaws in current form, (b) if such Person is a limited liability company, its limited
liability company agreement (or similar agreement), and (c) if such Person is a partnership or limited partnership, its partnership agreement
or limited partnership agreement (or similar agreement), each of the foregoing with all current amendments or modifications thereto.

 

    38

     

    

 

“Other
Connection Taxes” means, with respect to SVB, Taxes imposed as a result of a present or former connection between SVB and the
jurisdiction imposing such Tax (other than connections arising from SVB having executed, delivered, become a party to, performed its
obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant
to or enforced any Loan Document, or sold or assigned an interest in any Credit Extension or Loan Document).

 

“Other
Taxes” means all present or future stamp, court, documentary, intangible, recording, filing or similar Taxes that arise from
any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of
a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed
with respect to an assignment.

 

“Patents”
means all patents, patent applications and like protections including without limitation improvements, divisions, continuations, renewals,
reissues, extensions and continuations-in-part of the same.

 

“Payment/Advance
Form” is that certain form in the form attached hereto as Exhibit B.

 

“Payment
Date” is set forth on Schedule I hereto.

 

“Payment
Recipient” has the meaning assigned to it in Section 9.11(a).

 

“Perfection
Certificate” is the Perfection Certificate delivered by Borrower in connection with this Agreement.

 

“Permitted
Acquisition” or “Permitted Acquisitions” means the purchase or other acquisition (whether by merger, consolidation,
or otherwise) by Borrower of all or substantially all of the assets, stock or other equity interests of a Person, provided that each
of the following shall be applicable to each such acquisition:

 

(a)
no Event of Default shall have occurred and be continuing or would result from the consummation of the proposed acquisition and Agent
has received evidence that Borrower is in compliance with all terms and conditions of this Agreement on a pro forma basis after giving
effect to such acquisition;

 

(b)
the Person acquired or assets acquired is a type of business (or the assets are used in a type of business) permitted to be engaged by
Borrower under this Agreement;

 

(c)
the acquisition has been approved by the board of directors (or other legally governing body) of the Person to be acquired;

 

(d)
if such acquisition is a stock acquisition, the Person or Persons to be acquired shall be solely organized in the United States and shall
conduct their principal operations in the United States;

 

(e)
if the acquisition includes a merger of Borrower, Borrower shall remain the surviving legal entity after giving effect to such acquisition;

 

(f)
Borrower shall provide Agent with (i) written notice of the proposed acquisition at least ten (10) Business Days prior to the anticipated
closing date of the proposed acquisition, and (ii) not less than five (5) Business Days prior to the anticipated closing date of the
proposed acquisition, copies of the acquisition agreement and all other material documents relative to the proposed acquisition (or if
such acquisition agreement and other material documents are not in final form, drafts of such acquisition agreement and other material
documents; provided, that Borrower shall deliver final forms of such acquisition agreement and other material documents promptly upon
completion);

 

(g)
the consideration paid in connection with all such acquisitions consists solely of Borrower’s equity securities and such equity
securities shall not to exceed an aggregate value (for all such acquisitions during the life of this Agreement) of Eight Million Dollars
($8,000,000) with such value being measured as the close of trading on the day the certificate required under clause (j) hereof is delivered;

 

(h)
the entity or assets acquired in such acquisition shall not be subject to any Lien other (x) the first priority Liens granted in favor
of Agent and (y) Permitted Liens;

 

(i)
no Indebtedness will be incurred, assumed, or would exist with respect to Borrower or its Subsidiaries as a result of the contemplated
transaction, other than Permitted Indebtedness; and

 

(j)
Borrower shall have delivered to Agent, at least two (2) Business Days prior to the date on which any such acquisition is to be consummated
(or such later date as is agreed by Agent in its sole discretion), a certificate of a Responsible Officer of Borrower, in form and substance
reasonably satisfactory to Agent, certifying

 

(i)
that all of the requirements set forth in this definition have been satisfied or will be satisfied on or prior to the consummation of
such purchase or other acquisition and (ii) that (x) Borrower has enough cash on hand to pay its projected expenses and all debt service
when due for a period of twelve (12) months after the consummation of such transaction (after giving effect to such transaction) and
(y) Borrower’s projected annual cash burn after giving effect to such transaction will not increase by more than Two Hundred Thousand
Dollars ($200,000) per fiscal year for the two (2) years after the consummation of the transaction.

 

    39

     

    

 

“Permitted
Indebtedness” is:

 

(a)
Borrower’s Indebtedness to Agent and the Lenders under this Agreement and the other

 

Loan
Documents;

 

(b)
Indebtedness existing on the Effective Date which is shown on the Perfection Certificate;

 

(c)
Subordinated Debt;

 

(d)
unsecured Indebtedness to trade creditors incurred in the ordinary course of business;

 

(e)
Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business;

 

(f)
Indebtedness (i) owing from one Borrower to another Borrower; (ii) owing from Borrower to Subsidiaries that are not a Borrower hereunder,
and (iii) owing from Subsidiaries that are not a Borrower hereunder to Borrower in an aggregate amount not to exceed One Hundred Thousand
Dollars ($100,000) per fiscal year;

 

(g)
Indebtedness secured by Liens permitted under clauses (a) and (c) of the definition of “Permitted Liens” hereunder;

 

(h)
extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a) through (g) above; provided
that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower
or its Subsidiary, as the case may be; and

 

(i)
Unsecured Indebtedness not to exceed One Hundred Thousand Dollars ($100,000) at any time outstanding.

 

“Permitted
Investments” are:

 

(a)
Investments (including, without limitation, Subsidiaries) existing on the Effective Date which are shown on the Perfection Certificate;

 

(b)
Investments consisting of Cash Equivalents;

 

(c)
Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of Borrower’s business;

 

(d)
Investments consisting of deposit accounts (but only to the extent that Borrower is permitted to maintain such accounts pursuant to Section
5.7 of this Agreement) in which Agent has a first priority perfected security interest;

 

(e)
Investments accepted in connection with Transfers permitted by Section 6.1;

 

(f)
Investments consisting of the creation of a Subsidiary for the purpose of consummating a merger transaction permitted by Section 6.3
of this Agreement, which is otherwise a Permitted Investment;

 

(g)
Investments constituting Permitted Acquisitions;

 

(h)
Investments by (i) Borrower in Subsidiaries in an aggregate amount not to exceed (x) One Million Dollars ($1,000,000) in any calendar
month, and (y) (I) Six Million Dollars ($6,000,000) for the remainder (measured beginning on the Effective Date) of Borrower’s
2021 fiscal year, and (II) Three Million Dollars for each of Borrower’s fiscal years after the 2021 fiscal year, and (ii) by Subsidiaries
in other Subsidiaries in an aggregate amount not to exceed One Hundred Thousand Dollars ($100,000) per fiscal year; and

 

(i)
Investments (i) Borrower in another Borrower; (ii) by Borrower in Subsidiaries that are not a Borrower in an aggregate amount not to
exceed One Hundred Thousand Dollars ($100,000) in the aggregate in any fiscal year, and (iii) by Subsidiaries that are not a Borrower
in other Subsidiaries that are not a Borrower in an aggregate amount not to exceed One Hundred Thousand Dollars ($100,000) per fiscal
year;

 

(j)
Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course
of business, and (ii) loans to employees, officers, directors, partners, managers and members relating to the purchase of equity securities
of Borrower or its Subsidiaries pursuant to employee equity purchase plans or similar agreements approved by the Board;

 

(k)
Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business;
and

 

(l)
Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not
Affiliates, in the ordinary course of business; provided that this paragraph (l) shall not apply to Investments of Borrower in any Subsidiary.

 

    40

     

    

 

“Permitted
Liens” are:

 

(a)
Liens existing on the Effective Date which are shown on the Perfection Certificate or arising under this Agreement or the other Loan
Documents;

 

(b)
Liens for taxes, fees, assessments or other government charges or levies, either (i) not due and payable or (ii) being contested in good
faith and for which Borrower maintains adequate reserves on its Books, provided that no notice of any such Lien has been filed or recorded
under the Internal Revenue Code;

 

(c)
purchase money Liens (i) on Equipment acquired or held by Borrower incurred for financing the acquisition of the Equipment securing no
more than Fifty Thousand Dollars ($50,000) in the aggregate amount outstanding, or (ii) existing on Equipment when acquired, if the Lien
is confined to the property and improvements and the proceeds of the Equipment;

 

(d)
Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising in the ordinary course of business
so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed Fifty Thousand Dollars ($50,000)
and which are not delinquent or remain payable without penalty or which are being contested in good faith and by appropriate proceedings
which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto;

 

(e)
Liens to secure payment of workers’ compensation, employment insurance, old-age pensions, social security and other like obligations
incurred in the ordinary course of business (other than Liens imposed by ERISA);

 

(f)
Liens incurred in the extension, renewal or refinancing of the Indebtedness secured by Liens described in (a) through (c), but any extension,
renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the indebtedness
may not increase

 

(g)
leases or subleases of real property granted in the ordinary course of Borrower’s business (or, if referring to another Person,
in the ordinary course of such Person’s business), and leases, subleases, non-exclusive licenses or sublicenses of personal property
(other than Intellectual Property) granted in the ordinary course of Borrower’s business (or, if referring to another Person, in
the ordinary course of such Person’s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Agent
a security interest therein;

 

(h)
non-exclusive licenses of Intellectual Property granted to third parties in the ordinary course of business;

 

(i)
Liens arising from attachments or judgments, orders, or decrees in circumstances not constituting an Event of Default under Sections
7.4 and 7.7;

 

(j)
easements, rights-of-way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not substantial
in amount, and which do not in any case materially detract from the value of the property subject thereto or materially interfere with
the ordinary conduct of the business of the applicable Person; and

 

(k)
customary Liens of any bank in connection with statutory, common law and contractual rights of setoff and recoupment with respect to
any deposit account or securities account of Borrower, provided that

(i)
Agent has a first priority perfected security interest in such account and (ii) such account is permitted to be maintained pursuant to
Section 5.7 of this Agreement.

 

“Person”
is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization,
association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.

 

“Prepayment
Premium” shall be an additional fee, payable to Agent, for the ratable benefit of the Lenders based on their Pro Rata Share,
with respect to the Term Loan Advances, in an amount equal to:

 

(a)
for a prepayment of the Term Loan Advances made on or prior to the first (1st) anniversary of the Funding Date, three percent (3.0%)
of the then outstanding principal amount of the Term Loan Advances immediately prior to the date of such prepayment;

 

(b)
for a prepayment of the Term Loan Advances made after the first (1st) anniversary of the Funding Date, but on or prior to the second
(2nd) anniversary of the Funding Date, two percent (2.0%) of the then outstanding principal amount of the Term Loan Advances immediately
prior to the date of such prepayment; and

 

(c)
for a prepayment of the Term Loan Advances made after the second (2nd) anniversary of the Funding Date, but prior to the Term Loan Maturity
Date, one percent (1.0%) of the then outstanding principal amount of the Term Loan Advances immediately prior to the date of such prepayment.

 

    41

     

    

 

“Prime
Rate” is set forth on Schedule I hereto.

 

“Prime
Rate Margin” is set forth on Schedule I hereto.

 

“Pro
Rata Share” is, as of any date of determination,, with respect to each Lender, a percentage (expressed as a decimal, rounded
to the ninth decimal place) determined by dividing the outstanding principal amount of Term Loan Advances held by such Lender
by the aggregate outstanding principal amount of all Term Loan Advances.

 

“Receiver”
means an interim receiver, a receiver, a manager or a receiver and manager.

 

“Registered
Organization” is any “registered organization” as defined in the Code with such additions to such term as may hereafter
be made.

 

“Removal
Effective Date” is defined in Section 9.10(d).

 

“Representatives”
is defined in Section 12.8.

 

“Responsible
Officer” is any of the Chief Executive Officer, President and Chief Financial Officer of Borrower.

 

“Restricted
License” is any material license or other material agreement with respect to which Borrower is the licensee (a) that prohibits
or otherwise restricts Borrower from granting a security interest in, Borrower’s interest in such license or agreement or any other
property, or (b) for which a default under or termination of could interfere with the Agent’s right to sell any Collateral.

 

“Sanctioned
Person” means a Person that: (a) is listed on any Sanctions list maintained by OFAC or any similar Sanctions list maintained
by any other Governmental Authority having jurisdiction over Borrower; (b) is located, organized, or resident in any country, territory,
or region that is the subject or target of Sanctions; or (c) is fifty percent (50.0%) or more owned or controlled by one (1) or more
Persons described in clauses (a) and (b) hereof.

 

“Sanctions”
means the economic sanctions laws, regulations, embargoes or restrictive measures administered, enacted or enforced by the United States
government and any of its agencies, including, without limitation, OFAC and the U.S. State Department, or any other Governmental Authority
having jurisdiction over Borrower.

 

“SEC”
is the Securities and Exchange Commission, any successor thereto, and any analogous Governmental Authority.

 

“Securities
Account” is any “securities account” as defined in the Code with such additions to such term as may hereafter be
made.

 

“Subordinated
Debt” is indebtedness incurred by Borrower or any of its Subsidiaries subordinated to all of Borrower’s or any of its
Subsidiaries’ now or hereafter indebtedness to Agent and the Lenders (pursuant to a subordination, intercreditor, or other similar
agreement in form and substance satisfactory to Agent and the Lenders entered into between Agent, the Lenders, and the other creditor),
on terms acceptable to Agent and the Lenders.

 

“Subsidiary”
is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of stock, partnership,
membership, or other ownership interest or other equity securities having ordinary voting power (other than stock, partnership,
membership, or other ownership interest or other equity securities having such power only by reason of the happening of a
contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at
the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or
both, by such Person. Unless the context otherwise requires, each reference to a Subsidiary herein shall be a reference to a
Subsidiary of Borrower.

 

    42

     

    

 

“SVB”
is defined in the preamble hereof.

 

“SVB
Capital” is defined in the preamble hereof.

 

“Taxes”
means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees
or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.

 

“Term
Loan Advance” is defined in Section 1.1(a).

 

“Term
Loan Advance” and “Term Loan Advances” are each defined in Section 1.1 of this Agreement.

 

“Term
Loan Amortization Date” is set forth on Schedule I hereto.

 

“Term
Loan Commitment” means, for any Lender, the obligation of such Lender to make a Term Loan Advance as and when available, up
to the principal amount shown on Schedule II. “Term Loan Commitments” means the aggregate amount of such commitments
of all Lenders.

 

“Term
Loan Commitment Percentage” means, as to any Lender at any time, the percentage (carried out to the fourth decimal place) of
the Term Loan Commitments represented by such Lender’s Term Loan Commitment at such time. The initial Term Loan Commitment Percentage
of each Lender is set forth opposite the name of such Lender on Schedule II.

 

“Term
Loan Maturity Date” is set forth on Schedule I hereto.

 

“Trademarks”
means, with respect to any Person, any trademark and servicemark rights, whether registered or not, applications to register and registrations
of the same and like protections, and the entire goodwill of the business of such Person connected with and symbolized by such trademarks.

 

“Transfer”
is defined in Section 6.1.

 

“Uncommitted
Accordion” is defined in Section 1.1(a).

 

“Uncommitted
Accordion Draw Period” is set forth on Schedule I hereto.

 

“USA
Patriot Act” means the “Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
Terrorism Act of 2001” (Public Law 107-56, signed into law on October 26, 2001), as amended from time to time.

 

“Warrant”
means, collectively, (a) that certain warrant to purchase stock dated as of the Effective Date between Borrower and SVB, (b) that certain
warrant to purchase stock dated as of the Effective Date between Borrower and SVB Capital, in each case as may be amended, modified,
supplemented and/or restated from time to time and (c) any other warrant to purchase stock issued by Borrower in favor of SVB or SVB
Capital heretofore or hereafter, in each case as may be amended, modified, supplemented and/or restated from time to time.

 

[Signature
page follows]

 

    43

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the Effective

 

	Date.	 
	 	 	 
	BORROWER:	 
	 	 	 
	INMUNE
    BIO INC.	 
	 	 
	By:	/s/
David Moss	 
	Name:	David
    Moss	 
	Title:	CFO	 
		 	 
	AGENT:	 	 
	 	 
	SILICON
    VALLEY BANK, as Agent	 
	 	 	 
	By:	/s/
Michael White	 
	Name:	Michael
    White	 
	Title:	Head
    of Business Development	 
	 	 	 
	LENDERS:	 	 
	 	 	 
	SILICON
    VALLEY BANK, as Lender	 
	 	 	 
	By:	/s/
Michael White	 
	Name:	Michael
    White	 
	Title:	Head
    of Business Development	 
	 	 	 
	SVB
    INNOVATION CREDIT FUND VIII, L.P., as Lender	 
	By:
    SVB Innovation Credit Partners VIII, LLC, a	 
	Delaware
    limited liability company, its General	 
	Partner	 
	 	 	 
	By:	/s/
Ryan Grammar	 
	Name:	Ryan
    Grammar	 
	Title:	Senior
    Managing Director	 

 

Signature
Page to Loan and Security Agreement

 

SVB Confidential

 

     

     

    

  

SCHEDULE
I

 

LSA
PROVISIONS

 

	LSA Section	 	LSA Provision
	1.1(a) – Term Loan Advances – Availability	 	The Term Loan Advances must be in an amount equal to Fifteen Million Dollars ($15,000,000). The Uncommitted Accordion, if the Lenders, in their sole and absolute discretion, agree to accept a request from Borrower to make the Uncommitted Accordion available to Borrower, must be in an amount equal to at least Five Million Dollars ($5,000,000). Borrower may not request more than one (1) Term Loan Advance and one (1) Uncommitted Accordion advance hereunder.  After repayment, no Term Loan Advance (or any portion thereof) may be reborrowed.
	 	 	 
	1.1(b) – Term Loan Advances – Repayment	 	Commencing on the Term Loan Amortization Date and continuing on each Payment Date thereafter, Borrower shall repay the aggregate outstanding Term Loan Advances to Agent, for the account of the Lenders, in: (i) thirty (30) consecutive equal monthly installments of principal, plus (ii) monthly payments of accrued interest at the rate set forth in Section 1.2(b); provided, however, if Borrower achieves the Equity Event, Borrower shall repay the aggregate outstanding Term Loan Advances to Agent for the account of the Lenders, in (x) eighteen (18) consecutive equal monthly installments of principal, plus (y) monthly payments of accrued interest at the rate set forth in Section 1.2(b).
	 	 	 
	1.2(a) – Interest Payments – Term Loan Advances	 	Interest on the principal amount of each Term Loan Advance is payable in arrears monthly (A) on each Payment Date commencing on the first (1st) Payment Date of the month following the month in which the Funding Date of the applicable Term Loan Advance occurs, (B) on the date of any prepayment and (C) on the Term Loan Maturity Date.
	 	 	 
	1.2(b) – Interest Rate – Term Loan Advances	 	The outstanding principal amount of any Term Loan Advance shall accrue interest at a floating rate per annum equal to the greater of (A) seven and three-quarters percent (7.75%) and (B) the Prime Rate plus the Prime Rate Margin, which interest shall be payable in accordance with Section 1.2(a).
	 	 	 
	1.2(e) – Interest Computation	 	Interest shall be computed on the basis of the actual number of days elapsed.
	8.8 – Borrower Liability	 	Each Borrower hereunder shall be jointly and severally obligated to repay all Credit Extensions made hereunder and any other Obligations related thereto, regardless of which Borrower actually receives said Credit Extension, as if each Borrower hereunder directly received all Credit Extensions.
	 	 	 
	13.2 – “Borrower”	 	“Borrower” means INMUNE BIO INC., a Nevada corporation.
	 	 	 
	13.2 – “Uncommitted Accordion Draw Period”	 	“Uncommitted Accordion Draw Period” is, if the Lenders, in their sole and absolute discretion, agree to accept a request from Borrower to make the Uncommitted Accordion available to Borrower, the period of time beginning on Effective Date and ending on the earlier to occur of (a) December 31, 2022 and (b) an Event of Default.
	 	 	 
	13.2 – “Effective Date”	 	“Effective Date” is June 8, 2021.
	 	 	 
	13.2 – “Payment Date”	 	“Payment Date” is the first (1st) calendar day of each month.
	 	 	 
	13.2 – “Prime Rate”	 	“Prime Rate” is the rate of interest per annum from time to time published in the money rates section of The Wall Street Journal or any successor publication thereto as the “prime rate” then in effect; provided that if such rate of interest, as set forth from time to time in the money rates section of The Wall Street Journal, becomes unavailable for any reason as determined by Agent, the “Prime Rate” shall mean the rate of interest per annum announced by SVB as its prime rate in effect at its principal office in the State of California (such SVB announced Prime Rate not being intended to be the lowest rate of interest charged by SVB in connection with extensions of credit to debtors); provided that, in the event such rate of interest is less than zero percent (0.0%) per annum, such rate shall be deemed to be zero percent (0.0%) per annum for purposes of this Agreement.
	 	 	 
	13.2 – “Prime Rate Margin”	 	“Prime Rate Margin” is four and one-half percent (4.50%).
	 	 	 
	13.2 – “Term Loan Amortization Date”	 	“Term Loan Amortization Date” is July 1, 2022; provided, however, if Borrower achieves the Equity Event, the Term Loan Amortization Date shall automatically, with no further action required by the parties hereto, be extended to July 1, 2023.
	 	 	 
	13.2 – “Term Loan Maturity Date”	 	“Term Loan Maturity Date” is January 1, 2025.

    Sch I-1

     

    

 

SCHEDULE
II

 

LENDERS
AND COMMITMENTS

 

TERM
LOAN COMMITMENTS

 

	Lender	 	Term Loan Advance Commitment	 	 	Term Loan Advance Commitment Percentage	 
	Silicon Valley Bank	 	$	7,500,000	 	 	 	50.0000	%
	SVB Innovation Credit Fund VIII, L.P.	 	$	7,500,000	 	 	 	50.0000	%
	TOTAL	 	$	15,000,000	 	 	 	100.0000	%

 

    Sch II-1

     

    

 

EXHIBIT A

COMPLIANCE STATEMENT

 

	Date:	 	 
	 	 	 
	TO:	SILICON VALLEY BANK and SVB INNOVATION CREDIT FUND VIII, L.P.
	 	 
	FROM:	INMUNE BIO INC.	 

 

The
undersigned authorized officer of INMUNE BIO INC. (“Borrower”) certifies that under the terms
and conditions of the Loan and Security Agreement among Borrower, Agent, and the Lenders (the “Agreement”)
Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below. Attached
are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently
applied from one period to the next except as explained in an accompanying letter or footnotes. Capitalized terms used but not
otherwise defined herein shall have the meanings given them in the Agreement.

 

Please indicate compliance status by circling Yes/No
under “Complies” column.

 

	Reporting Covenants	 	Required	 	Complies
	 	 	 	 	 
	Monthly bank account statements	 	Monthly within 30 days	 	Yes   No
	 	 	 	 	 
	Quarterly Financial Statements with Compliance Statement	 	Quarterly within 45 days	 	Yes   No
	 	 	 	 	 
	Annual financial statement (CPA Audited)	 	FYE within 90 days	 	Yes   No
	 	 	 	 	 
	10-Q, 10-K and 8-K	 	Within 5 days after filing with SEC	 	Yes   No
	 	 	 	 	 
	Board approved projections	 	FYE within 30 days and as amended/updated	 	Yes   No
	 	 	 	 	 
	Assets at Subsidiaries	 	Aggregate value of assets held by any Subsidiaries of Borrower not to exceed $500,000 (or equivalent) in the aggregate for all such Subsidiaries at any time (the “Subsidiary Asset Cap”); provided, however, that such Subsidiaries may exceed the Subsidiary Asset Cap as the result of ordinary course cash transfers to pay vendors and for research and development expenses so long as the Subsidiary Asset Cap is not exceeded for more than 5 consecutive Business Days	 	Yes   No

 

Other Matters

 

	Have there been any material amendments of or other changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries? If yes, provide copies of any such amendments or changes with this Compliance Certificate.	Yes	No

 

The following are the exceptions with respect
to the certification above: (If no exceptions exist, state “No exceptions to note.”)

 

     Ex A-1

     

    

 

EXHIBIT B

LOAN PAYMENT/ADVANCE REQUEST FORM

 

Date: _____________________

 

Loan
Payment:

 

INMUNE BIO INC.

 

	From Account #	 	 	To Account #	 
	 	(Deposit Account #)	 	 	(Loan Account #)
	Principal $	 	 	and/or Interest $	 
	 	 	 	 	 
	Authorized Signature: 	 	 	Phone Number:	 
	Print Name/Title:	 	 	 	 

 

Loan
Advance:

 

Complete Outgoing Wire Request section below if all
or a portion of the funds from this loan advance are for an outgoing wire.

 

	From Account #	 	 	To Account #	 
	 	(Loan Account #)	 	 	(Deposit Account #)

 

	Amount of Term Loan Advance $	 	 	 	 

 

All Borrower’s representations and warranties
in the Loan and Security Agreement are true, correct and complete on the date of the request for an advance:

 

	Authorized Signature: 	 	 	Phone Number:	 
	Print Name/Title:	 	 	 	 

 

Outgoing
Wire Request:

Complete only if all or a portion of funds from the loan
advance above is to be wired.

Deadline for same day processing is noon, Pacific Time

 

	Beneficiary Name:	 	 	Amount of Wire: $ 	 
	Beneficiary Bank: 	 	 	Account Number:	 
	City and State:	 	 	 	 

 

	Beneficiary Bank Transit (ABA) #:	 	 	Beneficiary Bank Code (Swift, Sort, Chip, etc.):	 
	 	 	 	(For International Wire Only)	 

 

	Intermediary Bank:	 	 	Transit (ABA) #:	 

	For Further Credit to: 	 

 

	Special Instruction: 	 

 

By signing below, I (we) acknowledge and
agree that my (our) funds transfer request shall be processed in accordance with and subject to the terms and conditions set forth in
the agreements(s) covering funds transfer service(s), which agreements(s) were previously received and executed by me (us).

 

	Authorized Signature: 	 	 	2nd Signature (if required):	 
	Print Name/Title:	 	 	Print Name/Title:	 
	Telephone #:	 	 	Telephone #:	 

 

     Ex B-1

     

    

 

EXHIBIT C

Form of Disbursement Letter

 

[see attached]

 

     Ex C-1

     

    

 

DISBURSEMENT LETTER

 

_________ __, 20__

 

The undersigned, being the
Authorize Signer of INMUNE BIO INC. of, a Delaware corporation (“Borrower”), does hereby certify to (a) SILICON
VALLEY BANK, a California corporation (“SVB”), in its capacity as administrative agent and collateral agent (“Agent”),
(b) SVB, as a lender, (c) SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership (“SVB Capital”),
as a lender (SVB and SVB Capital and each of the other “Lenders” from time to time a party hereto are referred to herein collectively
as the “Lenders” and each individually as a “Lender”) in connection with that certain Loan and Security
Agreement dated as of June 8, 2021, by and among Borrower, Agent and the Lenders from time to time party thereto (the “Loan Agreement”;
with other capitalized terms used below having the meanings ascribed thereto in the Loan Agreement) that:

 

(i) The
representations and warranties made by Borrower in Section 4 of the Loan Agreement and in the other Loan Documents are true and correct
in all material respects as of the date hereof.

 

(ii) No
event or condition has occurred that would constitute an Event of Default under the Loan Agreement or any other Loan Document.

 

(iii) Borrower
is in compliance with the covenants and requirements contained in Sections 3,5 and 6 of the Loan Agreement.

 

(iv) All
conditions referred to in Section 2 of the Loan Agreement to the making of a Credit Extension to be made on or about the date hereof have
been satisfied or waived by Agent.

 

 (v) No Material Adverse Change has occurred.

 

 (vi) The undersigned is an Authorized Signer.

 

[Balance of Page Intentionally Left Blank]

 

     Ex C-2

     

    

 

7A. The
proceeds of the Term [A][B] Loan Advance shall be disbursed as follows:

 

	Disbursement from SVB:	 	 	 	 
	Loan Amount	 	$	    	 
	Plus:	 	 	 	 
	--Deposit Received	 	$	75,000	 
	Less:	 	 	 	 
	--Lenders’ Legal Fees	 	($	 	)*
	 	 	 	 	 
	Net Proceeds due from SVB:	 	$	 	 
	 	 	 	 	 
	Disbursement from SVB Capital:	 	 	 	 
	Loan Amount	 	$	 	 
	 	 	 	 	 
	Net Proceeds due from SVB Capital:	 	$	 	 
	TOTAL TERM [A][B] LOAN ADVANCE NET PROCEEDS FROM LENDERS	 	$	 	 

 

[Balance of Page Intentionally Left Blank]

 

     Ex C-3

     

    

 

8A. The aggregate net proceeds of the Term
[A][B] Loan Advance shall be transferred to the Borrower’s Designated Deposit Account as follows:

 

	Account Name:		 
	Bank Name:	Silicon Valley Bank	 
	Bank Address:	3003 Tasman Drive

Santa Clara, California 95054	 
	Account Number:		 
	ABA Number:		 

 

8B. Borrower authorized SVB to debit the Total Funds from the
Borrower’s Designated Deposit Account set forth below:

 

	Account Name:		 
	Bank Name:	Silicon Valley Bank	 
	Bank Address:	3003 Tasman Drive

Santa Clara, California 95054	 
	Account Number: 		 
	ABA Number:		 

 

[Balance of Page Intentionally Left Blank]

 

     Ex C-4

     

    

 

Dated as of the date first set forth above.

 

BORROWER:

 

INMUNE BIO INC.

 

	By:	 	 
	 	 	 
	Name: 	 	 
	 	 	 
	Title:	 	 

 

[Signature page continued on the following
page]

 

[Signature Page to Disbursement Letter]

 

     Ex C-5

     

    

 

AGENT:

 

SILICON VALLEY BANK

 

	By:	 	 
	 	 	 
	Name: 	 	 
	 	 	 
	Title:	 	 

 

LENDER:

 

SILICON VALLEY BANK

 

	By:	 	 
	 	 	 
	Name: 	 	 
	 	 	 
	Title:	 	 

 

LENDER:

 

SVB INNOVATION CREDIT FUND VIII, L.P.,

as Lender 

By: SVB Innovation Credit Partners VIII, LLC, a

Delaware limited liability company, its General

Partner

 

	By:	 	 
	 	 	 
	Name: 	 	 
	 	 	 
	Title:	 	 

 

     Ex C-6

     

    

 

ANNEX I

 

[Form of Warrant for Uncommitted Accordion to be
attached]

 

    Annex I-1

     

    

 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE
AND, EXCEPT AS SET FORTH IN SECTIONS 6.3 AND 6.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED
UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE
OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

 

WARRANT TO PURCHASE STOCK

 

This WARRANT TO PURCHASE STOCK
(as amended and in effect from time to time, this “Warrant”) is issued as of the issue date set forth on Schedule I
hereto (the “Issue Date”) by the company set forth on Schedule I hereto (the “Company”) to [SILICON
VALLEY BANK] [SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership] in connection with that certain Loan and Security
Agreement of even date herewith between them (as amended and/or modified and in effect from time to time, the “Loan Agreement”)
[for SVB: , and shall be transferred to SVB FINANCIAL GROUP pursuant to Section 6.4 below]. The parties agree as follows:

 

SCHEDULE
I. WARRANT PROVISIONS.

 

	Warrant Section	 	Warrant Provision
	 	 	 
	Recitals – “Issue Date”	 	________ __, 20__.
	 	 	 
	Recitals – “Company”	 	Inmune Bio, Inc., a Nevada corporation.
	 	 	 
	1.1 – “Class”	 	Common Stock
	 	 	 
	1.1 – “Exercise Price”	 	$[lower of (i) the average of the closing price of a share of Common Stock reported on NASDAQ for the 10 consecutive trading days ending immediately prior to the Issue Date and (ii) the closing price of a share of Common Stock reported on NASDAQ for the trading day ending immediately prior to the Issue Date] per Share.
	 	 	 
	1.2 – “Shares”	 	[$106,250 / Exercise Price]1
	 	 	 
	6.1(a) – “Expiration Date”	 	________ __, 20__.2

 

1 RIGHT TO PURCHASE
SHARES.

 

1.1 Grant of Right.
For good and valuable consideration, the Company hereby grants to [SILICON VALLEY BANK] [SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware
limited partnership] (together with any successor or permitted assignee or transferee of this Warrant or of any shares issued upon exercise
hereof, “Holder”) the right, and Holder is entitled, to purchase from the Company up to the number of fully paid and
non-assessable shares (as determined pursuant to Section 1.2 below) of the class set forth on Schedule I hereto (the “Class”),
at a purchase price per Share set forth on Schedule I hereto (the “Exercise Price”), subject to the provisions and
upon the terms and conditions set forth in this Warrant.

 

 

	1	NTD: Number of Shares listed here is what will be issued
to each of SVB and SVB Capital – total coverage for Term B Loans will be $212,500 (i.e. 4.25% X $5,000,000)

 

	2	NTD: 10 years after Issue Date.

 

    Annex I-2

     

    

 

1.2 Number of Shares.
This Warrant shall be exercisable for the number of shares of the Class as set forth on Schedule I hereto (as may be adjusted from time
to time in accordance with the provisions of this Warrant, the “Shares”).

 

 2  EXERCISE.

 

2.1 Method of Exercise.
Holder may exercise this Warrant in whole or in part at any time and from time to time prior to the expiration or earlier termination
of this Warrant, by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially
the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set forth
in Section 2.2 below, a check, wire transfer of same-day funds (to an account designated by the Company), or other form of payment acceptable
to the Company for the aggregate Exercise Price for the Shares being purchased. Notwithstanding any contrary provision herein, to the
extent that the original of this Warrant is an electronic original, in no event shall an original ink-signed paper copy of this Warrant
be required for any exercise of a Holder’s rights hereunder, nor shall this Warrant or any physical copy hereof be required to be
physically surrendered at the time of any exercise hereof.

 

2.2 Cashless Exercise.
On any exercise of this Warrant, in lieu of payment of the aggregate Exercise Price in the manner specified in Section 2.1 above, Holder
may elect to surrender to the Company Shares having an aggregate value equal to the aggregate Exercise Price. If Holder makes such election,
the Company shall issue to Holder such number of fully paid and non-assessable Shares determined by the following formula:

 

X = Y(A-B)/A

where:

 X
= the number of Shares to be issued to Holder;

Y
= the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in
payment of the aggregate Exercise Price);

A
= the fair market value (as determined pursuant to Section 2.3 below) of one Share; and

B =   the Exercise Price.

 

2.3 Fair Market
Value. If shares of the Company’s common stock are then traded or quoted on a nationally recognized securities exchange, inter-dealer
quotation system or over-the-counter market (a “Trading Market”) and the Class is common stock, the fair market value
of a Share shall be the closing price or last sale price of a share of the Company’s common stock reported for the Business Day
immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the Company. If shares of the
Company’s common stock are not then traded in a Trading Market, the Board of Directors of the Company shall determine the fair market
value of a Share in its reasonable good faith judgment.

 

2.4 Delivery of
Certificate and New Warrant. Within a reasonable time after Holder exercises this Warrant in the manner set forth in Sections 2.1
or 2.2 above, the Company shall deliver to Holder a certificate (or, in the case of uncertificated securities, provide notice of book
entry) representing the Shares issued to Holder upon such exercise and, if this Warrant has not been fully exercised and has not expired,
a new warrant of like tenor representing the Shares not so acquired (or surrendered in payment of the aggregate Exercise Price).

 

2.5    Replacement
of Warrant.

 

2.5.1 Paper Original
Warrant. To the extent that the original of this Warrant is a paper original, on receipt of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an
indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation, on surrender of
this Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this
Warrant, a new warrant of like tenor and amount.

 

    Annex I-3

     

    

 

2.5.2 Electronic
Original Warrant. To the extent that the original of this Warrant is an electronic original, if at any time this Warrant is
rejected by any person (including, but not limited to, paying or escrow agents) or any such person fails to comply with the terms of
this Warrant based on this Warrant being presented to such person as an electronic record or a printout hereof, or any signature
hereto being in electronic form, the Company shall, promptly upon Holder’s request and without indemnity, execute and deliver
to Holder, in lieu of electronic original versions of this Warrant, a new warrant of like tenor and amount in paper form with
original ink signatures.

 

2.6    Treatment
of Warrant Upon Acquisition of Company.

 

2.6.1 Acquisition.
“Acquisition” means any transaction or series of related transactions involving: (i) the sale, lease, exclusive license,
or other disposition of all or substantially all of the assets of the Company; (ii) any merger or consolidation of the Company into or
with another person or entity (other than a merger or consolidation effected exclusively to change the Company’s domicile), or any
other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior to such merger, consolidation
or reorganization, own less than a majority of the Company’s (or the surviving or successor entity’s or the ultimate parent
company of the surviving entity if the surviving entity if not the ultimate parent company) outstanding voting power immediately after
such merger, consolidation or reorganization; or (iii) any sale or other transfer by the stockholders of the Company of shares representing
at least a majority of the Company’s then-total outstanding combined voting power. For the avoidance of doubt, “Acquisition”
shall not include any sale and issuance by the Company of shares of its capital stock or of securities or instruments exercisable for
or convertible into, or otherwise representing the right to acquire, shares of its capital stock to one or more investors for cash in
a transaction or series of related transactions the primary purpose of which is a bona fide equity financing of the Company.

 

2.6.2 Treatment
of Warrant in Cash/Public Acquisition. In the event of an Acquisition in which the consideration to be received by the holders of
the outstanding shares of the Class (in their capacity as such) consists solely of cash, solely of Marketable Securities (as hereinafter
defined) or a combination of cash and Marketable Securities (a “Cash/Public Acquisition”), and the fair market value
of one Share as determined in accordance with Section 2.3 above would be greater than the Exercise Price in effect as of immediately prior
to the closing of such Cash/Public Acquisition, and Holder has not previously exercised this Warrant in full, then, in lieu of Holder’s
exercise of the unexercised portion of this Warrant, this Warrant shall, as of immediately prior to such closing (but subject to the occurrence
thereof) automatically cease to represent the right to purchase Shares and shall, from and after such closing, represent solely the right
to receive the aggregate consideration that would have been payable in such Acquisition on and in respect of all Shares for which this
Warrant was exercisable as of immediately prior to the closing thereof, net of the aggregate Exercise Price therefor, as if such Shares
had been issued and outstanding to Holder as of immediately prior to such closing, as and when such consideration is paid to the holders
of the outstanding shares of the Class. In the event of a Cash/Public Acquisition in which the fair market value of one Share as determined
in accordance with Section 2.3 above would be equal to or less than the Exercise Price in effect as of immediately prior to the closing
of such Cash/Public Acquisition, then this Warrant will automatically and without further action of any party terminate as of immediately
prior to such closing.

 

2.6.3 Treatment
of Warrant in non-Cash/Public Acquisition. Upon the closing of any Acquisition other than a Cash/Public Acquisition, the acquiring,
surviving or successor entity shall assume this Warrant and the Company’s obligations hereunder, and this Warrant shall thereafter
be exercisable for the same securities and/or other property as would have been paid for the Shares issuable upon exercise of the unexercised
portion of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition, at an aggregate Exercise Price
equal to the aggregate Exercise Price in effect as of immediately prior to such closing, all subject to further adjustment from time to
time thereafter in accordance with the provisions of this Warrant.

 

    Annex I-4

     

    

 

2.6.4 Marketable
Securities. “Marketable Securities” means securities meeting all of the following requirements (determined as
of immediately prior to the closing of the Acquisition): (i) the issuer thereof is then subject to the reporting requirements of
Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is then
current in its filing of all required reports and other information under the Act and the Exchange Act; (ii) the class and series of
shares or other security of the issuer that would be received by Holder in connection with the Acquisition were Holder to exercise
this Warrant on or prior to the closing thereof is then traded in a Trading Market, and (iii) following the closing of such
Acquisition, Holder would not be restricted from publicly re-selling all of the issuer’s shares and/or other securities that
would be received by Holder in such Acquisition were Holder to exercise this Warrant in full on or prior to the closing of such
Acquisition, except to the extent that any such restriction (x) arises solely under federal or state securities laws, rules or
regulations, and (y) does not extend beyond six (6) months from the closing of such Acquisition. Notwithstanding the foregoing
provisions of this Section 2.6(d), securities held in escrow or subject to holdback to cover indemnification-related claims shall
be deemed to be Marketable Securities if they would otherwise be Marketable Securities but for the fact that they are held in escrow
or subject to holdback to cover indemnification-related claims.

 

 3 CERTAIN ADJUSTMENTS TO THE SHARES, CLASS AND EXERCISE PRICE.

 

3.1 Stock Dividends,
Splits, Etc. If the Company declares or pays a dividend or distribution on the outstanding shares of the Class payable in additional
shares of the Class (including fractional shares) or other securities or property (other than cash), then upon exercise of this Warrant,
for each Share acquired, Holder shall receive, without additional cost to Holder, the total number and kind of securities and property
which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company
subdivides the outstanding shares of the Class by reclassification or otherwise into a greater number of shares, the number of Shares
purchasable hereunder shall be proportionately increased, even if such number would include fractional shares, and the Exercise Price
shall be proportionately decreased. If the outstanding shares of the Class are combined or consolidated, by reclassification or otherwise,
into a lesser number of shares, the Exercise Price shall be proportionately increased and the number of Shares shall be proportionately
decreased, even if such number would include fractional shares.

 

3.2 Reclassification,
Exchange, Combination or Substitution. Upon any event whereby all of the outstanding shares of the Class are reclassified, exchanged,
combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the
consummation of such event, “Class” shall mean such securities and this Warrant will be exercisable for the number of such
securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, at an aggregate
Exercise Price equal to the aggregate Exercise Price in effect as of immediately prior to such event, all subject to further adjustment
thereafter from time to time in accordance with the provisions of this Warrant. The provisions of this Section 3.2 shall similarly apply
to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events.

 

3.3 Adjustment to
Exercise Price on Cash Dividend. In the event that the Company at any time or from time to time prior to the exercise in full of this
Warrant pays any cash dividend on the outstanding shares of the Class or makes any cash distribution on or in respect of all outstanding
shares of the Class (other than a distribution of cash proceeds received by the Company in connection with an Acquisition described in
Section 2.6(a)(i) above), then on and as of the date of each such dividend payment and/or distribution, the Exercise Price shall be
reduced by an amount equal to the amount paid or distributed upon or in respect of each outstanding share of the Class; provided that
in no event shall the Exercise Price be reduced below the then-par value, if any, of a share of the Class.

 

3.4 No Fractional
Share. No fractional Share shall be issued upon exercise of this Warrant, and the number of Shares to be issued shall be rounded down
to the nearest whole Share. If a fractional Share interest arises upon any exercise of this Warrant, the Company shall eliminate such
fractional Share interest by paying Holder in cash an amount equal to (a) such fractional interest, multiplied by (b)(i) the fair market
value (as determined in accordance with Section 2.3 above) of a full Share, less (ii) the then-effective Exercise Price (the “Fractional
Share Value”), unless Holder otherwise elects, in its sole discretion, to waive such payment. Notwithstanding any contrary provision
herein, if this Warrant becomes exercisable for a fractional Share interest at any time or from time to time prior to the exercise in
full of this Warrant, and the Company eliminates such fractional Share interest prior to any exercise of this Warrant, then the then-effective
Exercise Price shall be reduced by an amount equal to the Fractional Share Value, unless Holder otherwise elects, in its sole discretion,
to waive such reduction.

 

    Annex I-5

     

    

 

3.5 Certificate
as to Adjustments. Within a reasonable time following each adjustment of the Exercise Price, Class and/or number of Shares
pursuant to the terms of this Warrant, the Company, at its expense, shall deliver a certificate of its Chief Financial Officer or
other authorized officer to Holder setting forth the adjustments to the Exercise Price, Class and/or number of Shares and the facts
upon which such adjustments are based. The Company shall, at any time and from time to time within a reasonable time following
Holder’s written request and at the Company’s expense, furnish Holder with a certificate of its Chief Financial Officer
or other authorized officer setting forth the then-current Exercise Price, Class and number of Shares and the computations or other
determinations thereof.

 

 4 REPRESENTATIONS AND COVENANTS OF THE COMPANY.

 

4.1 Representations
and Warranties. The Company represents and warrants to, and agrees with, Holder as follows:

 

4.1.1 The initial Warrant
Price referenced on the first page of this Warrant is not greater than the lower of (i) the average of the closing price of a share of
Common Stock reported on the Trading Market for the 10 consecutive trading days ending immediately prior to the Issue Date and (ii) the
closing price of a share of Common Stock reported on the Trading Market for the trading day ending immediately prior to the Issue Date.

 

4.1.2 All Shares which
may be issued upon the exercise of this Warrant, shall, upon issuance, be duly authorized, validly issued, fully paid and non-assessable,
and free of any liens and encumbrances except for restrictions on transfer provided for herein or under the Company’s Certificate
of Incorporation or Bylaws, each as amended and in effect from time to time (the “Charter Documents”), any stockholder
agreement (to the extent Holder is then a party thereto or otherwise subject thereto in accordance with the provisions of Section 5.4
below) or applicable federal and state securities laws. The Company covenants that it shall at all times cause to be reserved and kept
available out of its authorized and unissued capital stock such number of shares of the Class and other securities as will be sufficient
to permit the exercise in full of this Warrant.

 

4.2    Notice
of Certain Events. If the Company proposes at any time to:

 

4.2.1 declare any dividend
or distribution upon the outstanding shares of the Class, whether in cash, stock or other securities or property and whether or not a
regular cash dividend;

 

4.2.2 offer for subscription
or sale pro rata to all holders of the outstanding shares of the Class any additional securities of the Company (other than pursuant to
contractual pre-emptive or first refusal rights);

 

4.2.3 effect any redemption,
reclassification, exchange, combination, substitution, reorganization or recapitalization of the outstanding shares of the Class; or

 

4.2.4  effect an Acquisition, or to
liquidate, dissolve or wind up the Company; then, in connection with each such event, the Company shall give Holder (pursuant to
Section 6.5 below):

 

(a)    in
the case of the matters referred to in (a) and (b) above, at least seven (7) Business Days prior written notice of the earlier to occur
of the effective date thereof or the date on which a record will be taken for such dividend, distribution, or subscription rights (and
specifying the date on which the holders of outstanding shares of the Class will be entitled thereto) or for determining rights to vote,
if any; and

 

(b)    in
the case of the matters referred to in (c) and (d) above, at least seven (7) Business Days prior written notice of the date when the same
will take place (and specifying the date on which the holders of outstanding shares of the Class will be entitled to exchange their shares
for the securities or other property deliverable upon the occurrence of such event and such reasonable information as Holder may reasonably
require regarding the treatment of this Warrant in connection with such event giving rise to the notice).

 

4.3 Certain Company
Information. The Company will provide such information requested by Holder from time to time, within a reasonable time following each
such request, that is reasonably necessary to enable Holder to comply with Holder’s accounting or reporting requirements.

 

    Annex I-6

     

    

 

 5 REPRESENTATIONS AND COVENANTS OF HOLDER.

 

Holder represents and warrants to, and agrees with, the Company
as follows:

 

5.1    Investment
Representations.

 

5.1.1 Purchase for
Own Account. [for SVB: Except for the one-time transfer of this Warrant from Silicon Valley Bank to its parent SVB Financial
Group described in Section 6.4 below,] [T][t]his Warrant and the Shares to be acquired upon exercise hereof are being acquired for investment
for Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of
the Act. Holder also represents that it has not been formed for the specific purpose of acquiring this Warrant or the Shares.

 

5.1.2 Disclosure
of Information. Holder is aware of the Company’s business affairs and financial condition and has received or has had full access
to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of
this Warrant and its underlying securities. Holder further has had an opportunity to ask questions of and receive answers from the Company
regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information
(to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify
any information furnished to Holder or to which Holder has access.

 

5.1.3 Investment
Experience. Holder understands that the purchase of this Warrant and its underlying securities involves substantial risk. Holder has
experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk
of such Holder’s investment in this Warrant and its underlying securities for an indefinite period of time, and has such knowledge
and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant
and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of its officers,
directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial
circumstances of such persons.

 

5.1.4 Accredited
Investor Status. Holder is an “accredited investor” within the meaning of Regulation D promulgated under the Act.

 

5.1.5 The Act.
Holder understands that this Warrant and the Shares issuable upon exercise hereof have not been registered under the Act or registered
or qualified under the securities laws of any state, and are issued in reliance upon specific exemptions therefrom, which exemptions depend
upon, among other things, the bona fide nature of the Holder’s investment intent as expressed herein. Holder understands that the
Company is under no obligation to so register or qualify this Warrant, the Shares or such other securities. Holder understands that this
Warrant and the Shares issued upon any exercise hereof are “restricted securities” under applicable federal and state securities
laws and must be held indefinitely unless subsequently registered under the Act and registered or qualified under applicable state securities
laws, or unless exemptions from such registration and qualification are otherwise available. Holder is aware of the provisions of Rule
144 promulgated under the Act.

 

5.2 No Stockholder
Rights. Without limiting any provision of this Warrant, Holder agrees that as a Holder of this Warrant it will not have any rights
(including, but not limited to, voting rights) as a stockholder of the Company with respect to the Shares issuable hereunder unless and
until the exercise of this Warrant and then only with respect to the Shares issued on such exercise.

 

5.3 Confidential
Information. Holder agrees to treat and hold all information provided by the Company pursuant to this Warrant in confidence in accordance
with the provisions of Section 12.8 of the Loan Agreement (regardless of whether the Loan Agreement shall then be in effect).

 

 6 MISCELLANEOUS.

 

6.1    Term;
Automatic Cashless Exercise Upon Expiration.

 

    Annex I-7

     

    

 

6.1.1 Term.
Subject to the provisions of Section 2.6 above, this Warrant is exercisable in whole or in part at any time and from time to time on or
before 6:00 PM, Pacific time, on the expiration date set forth on Schedule I hereto (the “Expiration Date”) and shall
be void thereafter; provided that if the Company does not deliver to Holder written confirmation of the fair market value of a Share pursuant
to Section 6.1(b) below, then the Expiration Date shall automatically be extended until the earlier to occur of (i) such date as the
Company delivers such written confirmation and (ii) one (1) year after the Expiration Date.

 

6.1.2 Automatic
Cashless Exercise upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share as determined in
accordance with Section 2.3 above is greater than the Exercise Price in effect on such date, then this Warrant shall automatically be
deemed on and as of such date to be exercised pursuant to Section 2.2 above as to all Shares for which it shall not previously have been
exercised, and the Company shall, within a reasonable time following Holder’s written request, deliver a certificate (or, in the
case of uncertificated securities, provide notice of book entry) representing the Shares issued to Holder upon such exercise. If shares
of the Company’s common stock are not then traded in a Trading Market, the Company shall deliver to Holder, prior to the Expiration
Date, written confirmation of the fair market value of a Share (as determined pursuant to Section 2.3 above) to be used in determining
whether this Warrant shall automatically exercise on the Expiration Date pursuant to this Section 6.1(b).

 

6.2 Legends.
Each certificate or notice of book entry evidencing Shares shall be imprinted with a legend in substantially the following form (together
with such additional legends as may be required by the Charter Documents):

 

THE SHARES EVIDENCED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO [SILICON VALLEY BANK]
[SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership] DATED ________ __, 20__, MAY NOT BE OFFERED, SOLD, PLEDGED
OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

 

And, if then applicable, a legend in substantially the following form:

 

THE SECURITIES EVIDENCED BY THIS
CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE
OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH IN THAT CERTAIN
WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO [SILICON VALLEY BANK] [SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited
partnership] DATED ________ __, 20__, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH RESTRICTIONS ARE
BINDING ON TRANSFEREES OF THESE SECURITIES.

 

6.3 Compliance with
Securities Laws on Transfer. This Warrant and the Shares issued upon exercise hereof may not be transferred or assigned in whole or
in part except in compliance with applicable federal and state securities laws by the transferor and the transferee (including, without
limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonably
requested by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to SVB Financial Group
(Silicon Valley Bank’s parent company) or any other affiliate of Holder; provided that any such transferee is an “accredited
investor” as defined in Regulation D promulgated under the Act.

 

    Annex I-8

     

    

 

6.4 Transfer Procedure.
[For SVB: After receipt by Silicon Valley Bank of the executed Warrant, Silicon Valley Bank will transfer, for value received,
all of its rights, title and interest in and to this Warrant to its parent company, SVB Financial Group, without any separate assignment
agreement. By its acceptance of this Warrant, SVB Financial Group, on and as of the date of such assignment, hereby makes to the Company
each of the representations and warranties set forth in Section 5.1 hereof and agrees to be bound by all of the terms and conditions of
this Warrant as if it were the original Holder hereof.] Subject to the provisions of Section 6.3 and upon providing the Company with written
notice, [For SVB: SVB Financial Group][Holder] and any subsequent Holder may transfer all or part of this Warrant or the Shares
issued upon exercise of this Warrant to any transferee; provided that in connection with any such transfer, SVB Financial Group or any
subsequent Holder will give the Company notice of the portion of the Warrant and/or Shares being transferred with the name, address and
taxpayer identification number of the transferee, and Holder will surrender this Warrant, or the certificates or other evidence of such
Shares or other securities, to the Company for reissuance to the transferee(s) (and to Holder if applicable); and provided further, that
any subsequent transferee [For SVB: other than SVB Financial Group] shall make substantially the representations set forth in Section
5.1 above and shall agree in writing with the Company to be bound by all of the terms and conditions of this Warrant.

 

6.5 Notices.
All notices and other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered and effective
(i) when given personally, (ii) on the third (3rd) Business Day after being mailed by first-class registered or certified mail, postage
prepaid, (iii) upon actual receipt if given by electronic mail and such receipt is confirmed in writing by the recipient, or (iv) on the
first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such address as may
have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to time in accordance
with the provisions of this Section 6.5. All notices to Holder shall be addressed as follows until the Company receives notice of a change
of address in connection with a transfer or otherwise:

 

[SVB Financial Group

Attn: Warrants

80 East Rio Salado Parkway, Suite 600

Tempe, AZ 85281

Telephone: (480) 557-4900

Email: SVBFGWarrants@svb.com]

 

[SVB Innovation Credit Fund VIII, L.P.

c/o SVB Capital

2770 Sand Hill Road

Menlo Park, CA 94025

Attn: SVB Capital Finance and Operations

Email: svbcapitalcredit@svbank.com; and SVBCapCreditFinance@svb.com]

 

All notices to the Company shall be addressed as follows
until Holder receives notice of a change in address:

 

INMUNE BIO, INC.

Attn: Chief Financial Officer

1200 Prospect Street, Suite 525

La Jolla, CA 92037

Telephone: _________________

Email: ____________________

 

6.6 Amendment and
Waiver. Notwithstanding any contrary provision herein or in the Loan Agreement, this Warrant may be amended and any provision hereof
waived (either generally or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed
by Holder and any party against which enforcement of such amendment or waiver is sought.

 

6.7 Counterparts;
Electronic Signatures; Status as Certificated Security. This Warrant may be executed by one or more of the parties hereto in any number
of separate counterparts, all of which together shall constitute one and the same instrument. The Company, Holder and any other party
hereto may execute this Warrant by electronic means and each party hereto recognizes and accepts the use of electronic signatures and
the keeping of records in electronic form by any other party hereto in connection with the execution and storage hereof. To the extent
that this Warrant or any agreement subject to the terms hereof or any amendment hereto is executed, recorded or delivered electronically,
it shall be binding to the same extent as though it had been executed on paper with an original ink signature, as provided under applicable
law, including, without limitation, any state law based on the Uniform Electronic Transactions Act. The fact that this Warrant is executed,
signed, stored or delivered electronically shall not prevent the transfer by any Holder of this Warrant pursuant to Section 6.4 or the
enforcement of the terms hereof. To the extent that the original of this Warrant is an electronic original, this Warrant, and any copies
hereof, shall NOT be deemed to be a “certificated security” within the meaning of Section 8102(a)(4) of the California Commercial
Code. Physical possession of the original of this Warrant or any paper copy thereof shall confer no special status to the bearer thereof.

 

    Annex I-9

     

    

 

6.8 Headings.
The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision of
this Warrant.

 

6.9 Business Days.
“Business Day” means any day that is not a Saturday, Sunday or a day on which banks in California are closed.

 

 7 GOVERNING LAW, VENUE AND JURY TRIAL WAIVER; JUDICIAL REFERENCE.

 

7.1 Governing Law.
This Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles
regarding conflicts of law.

 

7.2 Jurisdiction
and Venue. The Company and Holder each irrevocably and unconditionally submit to the exclusive jurisdiction of the State and Federal
courts in Santa Clara County, California; provided, however, that nothing in this Warrant shall be deemed to operate to preclude Holder
from bringing suit or taking other legal action in any other jurisdiction to enforce a judgment or other court order in favor of Holder.
The Company expressly, irrevocably and unconditionally submits and consents in advance to such jurisdiction in any action or suit commenced
in any such court, and the Company hereby irrevocably and unconditionally waives, to the fullest extent permitted by applicable law, any
objection that it may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby irrevocably and
unconditionally consents to the granting of such legal or equitable relief as is deemed appropriate by such court. The Company hereby
waives personal service of the summons, complaints, and other process issued in such action or suit and agrees that service of such summons,
complaints, and other process may be made by registered or certified mail addressed to the Company in accordance with Section 6.5 of this
Warrant and that service so made shall be deemed completed upon the earlier to occur of the Company’s actual receipt thereof of
three (3) days after deposit in the U.S. mails, proper postage prepaid.

 

7.3 Jury Trial Waiver.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE COMPANY AND HOLDER EACH WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE
OF ACTION ARISING OUT OF OR BASED UPON THIS WARRANT, THE LOAN AGREEMENT OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH
OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES’ AGREEMENT TO THIS WARRANT. EACH PARTY HERETO
HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.

 

7.4 Judicial
Reference. WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES’ AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY
JURY, if the waiver of the right to a trial by jury in Section 7.3 above is not enforceable, the parties hereto agree that any
and all disputes or controversies of any nature between them arising at any time shall be decided by a reference to a private judge,
mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior
Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal
law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County,
California; and the parties hereby submit to the jurisdiction of such court. The reference proceedings shall be conducted pursuant
to and in accordance with the provisions of California Code of Civil Procedure Sections 638 through 645.1, inclusive. The private
judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining
orders, issuing preliminary and permanent injunctions and appointing receivers. All such proceedings shall be closed to the public
and confidential and all records relating thereto shall be permanently sealed. If during the course of any dispute, a party desires
to seek provisional relief, but a judge has not been appointed at that point pursuant to the judicial reference procedures, then
such party may apply to the Santa Clara County, California Superior Court for such relief. The proceeding before the private judge
shall be conducted in the same manner as it would be before a court under the rules of evidence applicable to judicial proceedings.
The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules
of discovery applicable to judicial proceedings. The private judge shall oversee discovery and may enforce all discovery rules and
orders applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or
appointed private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall
report a statement of decision thereon pursuant to California Code of Civil Procedure Section 644(a). Nothing in this Section 7.4
shall limit the right of any party at any time to exercise self-help remedies or obtain provisional remedies. The private judge
shall also determine all issues relating to the applicability, interpretation, and enforceability of this Section 7.4.

 

7.5    Survival.
This Section 7 shall survive the termination of this Warrant.

 

[Signature page follows]

 

    Annex I-10

     

    

 

IN WITNESS WHEREOF, the parties have caused
this Warrant To Purchase Stock to be executed by their duly authorized representatives effective as of the Issue Date written above.

 

	 	COMPANY:
	 	 
	 	INMUNE BIO, INC.
	 	 
	 	By:	             
	 	Name:	 
	 	Title:	 
	 	 
	 	HOLDER:
	 	 
	 	[SILICON VALLEY BANK] [SVB INNOVATION CREDIT FUND VIII, L.P.]
	 	 
	 	By:	 
	 	Name: 	 
	 	Title:	 

 

    Annex I-11

     

    

 

APPENDIX 1

 

Form of Notice of Exercise of Warrant

 

(i)    The
undersigned Holder hereby exercises its right to purchase ___________ shares of the Common Stock of INMUNE BIO, INC. (the “Company”)
in accordance with the attached Warrant to Purchase Stock, and tenders payment of the aggregate Exercise Price for such shares as follows:

 

	☐	Check in the amount of $________ payable to the order of the Company enclosed herewith
	 	 
	☐	Wire transfer of immediately available funds to the Company’s account
	 	 
	☐	Cashless exercise pursuant to Section 2.2 of the Warrant, resulting in the issuance of __________________ shares of the Common Stock of the Company
	 	 
	☐	Other [Describe] __________________________________________

 

(ii)    Please
issue a certificate or certificates (or evidence of book entry) representing the Shares in the name specified below:

 

___________________________________________

Holder’s Name

 

___________________________________________

 

___________________________________________

(Address)

 

(iii)    By
its execution below and for the benefit of the Company, Holder hereby makes each of the representations and warranties set forth in Section
5.1 of the Warrant To Purchase Stock as of the date hereof.

 

	 	HOLDER:
	 	 	 
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	(Date) :	 

 

 

Appendix 1-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]